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The present dissertation focuses on the phytochemical study of Euphorbia boetica 
Boiss. and Euphorbia pubescens Vahl (Euphorbiaceae) aerial parts in an attempt to find 
effective modulators for P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in 
tumour cells. 
The methanol extracts of both plants were fractioned by chromatographic techniques 
such as column chromatography, preparative thin layer chromatography and high-performance 
liquid chromatography (HPLC). From the methanol extract of E. boetica, one new 
premyrsinane-type diterpene with the unusual 5:7:6:3 fused ring system and a new acylation 
pattern, named euphomyrsinane A, two new tigliane-type diterpenes with new acylation 
patterns, named phorboboetirane A and phorboboetirane B along with four known macrocyclic 
diterpenes, premyrsinol-3-propanoate-5-benzoate-7,13,17-triacetate, euphoboetirane A, 
epoxyboetirane A and epoxyboetirane K were isolated. A known triterpene with the 
cycloartane skeleton, 24-methylenecycloartanol, and a phenolic compound, methyl gallate 
were also isolated. From the methanol extracts of E. pubescens, were obtained a known 
macrocyclic diterpene, euphopubescenol, and a known diterpenic lactone, helioscopinolide A. 
Due to its biological activity and simple structure paired with the fact that it was isolated 
in large amounts, methyl gallate was derivatized, aiming at generating a small set of bioactive 
derivatives. In this way, taking into account that lipophilicity and the presence of nitrogen 
atoms are described to improve the ability to reverse MDR, three main steps were considered: 
i) methylation of the hydroxyl groups on the aromatic ring by reaction with dimethylsulfate, 
yielding methyl 3,4,5-trimethoxebenzoate; ii) reaction of methyl 3,4,5-trimethoxybenzoate 
with hydrazine yielding 3,4,5-trimethoxybenzohydrazide; iii) condensation of 3,4,5-
trimethoxybenzohydrazide with aromatic aldehydes to obtain three derivatives bearing an 
imine moiety. 
The chemical structures of the compounds were deduced from their physical and 
spectroscopic data, which included infrared spectroscopy, mass spectrometry and extensive 
one- (1H-NMR, 13C-NMR, DEPT) and two-dimensional (1H-1H-COSY, HMQC, HMBC, and 
NOESY) Nuclear Magnetic Resonance studies and by comparison with literature data. 
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A presente dissertação descreve o estudo fitoquímico de algumas frações dos extratos 
metanólicos das partes aéreas da Euphorbia boetica Boiss. e Euphorbia pubescens Vahl 
(Euphorbiaceae) com o intuito de encontrar moduladores eficientes na multirresistência 
farmacológica mediada pela glicoproteína-P, em células tumorais. 
O fracionamento dos extratos metanólicos foi realizado através de varias técnicas, 
nomeadamente cromatografia em coluna, cromatografia preparativa em camada fina e 
cromatografia líquida de alta eficiência (HPLC). Do extrato metanólico da E. boetica, foram 
isolados e caracterizados um novo diterpeno com o esqueleto do premirsinano apresentando 
um sistema de anéis 5:7:6:3 fundidos, com um novo rearranjo e um novo padrão de acilação, 
nomeado euphomyrsinane A e dois diterpenos com o esqueleto do tigliano com novos padrões 
de acilação, designados phorboboetirane A e phorboboetirane B. Foram ainda isolados: quatro 
diterpenos macrocíclicos já conhecidos, premirsinol-3-propanoato-5-benzoato-7,13,17-
triacetato, eufoboetirano A, epoxiboetirano A e epoxiboetirano K; um triterpeno conhecido 
com o esqueleto do cicloartano, 24-metilenocicloartanol; e um composto fenólico, o galhato 
de metilo. Dos extratos metanólicos da E. pubescens, foram isolados e identificados um 
diterpeno macrocíclico conhecido, euphopubescenol, e uma lactona diterpénica conhecida, 
helioscopinolido A. 
Dada a sua atividade biológica e estrutura simples, associado ao facto de ter sido isolado 
em grande quantidade, o galhato de metilo foi derivatizado, com o objetivo de criar um pequeno 
conjunto de derivados bioativos. Desta forma, e tendo em conta que a lipofilia e presença de 
átomos de azoto aumentam as propriedades moduladoras dos compostos, foram considerados 
três passos: i) metilação dos grupos hidroxilo do anel benzénico através de reação com 
dimetilsulfato, obtendo 3,4,5-trimetoxibenzoato de metilo; ii) reação do 3,4,5-
trimetoxibenzoato de metilo com hidrazina para obter a 3,4,5-trimetoxibenzo-hidrazida; iii) 
condensação da 3,4,5-trimetoxibenzo-hidrazida com aldeídos aromáticos para obter derivados 
com a função imina. 
A estrutura química de todos os compostos foi deduzida com base as suas características 
físicas e espetroscópicas, incluindo espetroscopia de infravermelho (IV), espetrometria de 
massa, RMN unidimensional (1H-RMN, 13C-RMN, DEPT) e bidimensional (1H-1H-COSY, 
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1. GENERAL CONSIDERATIONS 
 
Since ancient times, plants have been at the core of human healthcare and are the main 
source for chemically active compounds for numerous purposes, including therapeutic agents 
[1]. Documents like the Ayurveda (Indian Traditional Medicine), which can be traced back to 
around 5000 BC, introduced some medicinal properties of plants and other natural products. 
Although the mechanisms by which the plants and other natural products were effective at 
treating the illnesses were unknown, nowadays, modern developments in areas such as 
chemistry, spectroscopic techniques, and High Throughput Screening (HTS) coupled with 
modern hyphenated techniques (e.g. GC-MS, LC-MS) made it easier to isolate and study the 
bioactivity of purified natural products [1-3]. 
Usually, the term natural product is used to refer to secondary metabolites produced by 
any living organism to enhance their survivability. These secondary metabolites are 
biosynthesized in a particular chiral form to exhibit biological activity in in vitro and in vivo 
test systems, helping major pharmaceutical companies by providing lead compound structures 
[2]. 
 
1.1. Euphorbia L. Genus – General considerations 
 
The Euphorbiaceae family consists of around 300 genera and over 7000 species and is 
considered one of the largest families of flowering plants. Commonly known as “spurge” for 
the purgative properties of its latex [4], the Euphorbia genus is widely distributed worldwide, 
consisting approximately of 2160 species, subdivided into many subgenera and sections [5]. 
Plants from this genus are characterized by a wide range of annual or perennial herbs, woody 
shrubs, trees and succulent plants, all possessing a flower-like inflorescence and often 
containing a toxic milky latex [1, 6]. The name Euphorbia came to be in honour of Euphorbius, 
King Juba II of Mauretania’s physician, who is supposed to have used the milky latex from 
Euphorbia resinifera as a remedy [7]. 
Widely used in traditional medicines, Euphorbia species are known to treat several 
diseases such as skin ulcers, tumours and intestinal parasites [8]. In the Chinese 
pharmacopoeias, five species of Euphorbia, namely E. pekinensis, E. kansui, E. lathyris, E. 
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humifusa and E. maculata are recommended for the treatment of oedema, gonorrhoea, 
migraines and warts, even though they are known to be extremely poisonous [5, 9]. 
Despite its traditional applications, the aforementioned toxic latex, causes extremely 
painful inflammations when in contact with mucous membranes and has hindered further uses 
of Euphorbias as medicines. This milky latex is rich in many diterpenes, triterpenes, 
sesquiterpenes and steroids, and its toxicity is attributed to the polycyclic diterpenoids with the 
ingenane, tigliane and daphnane scaffolds, also known as phorboids, compounds which are 
exclusive to the Euphorbiaceae and Thymelaeaceae families [8]. 
Nevertheless, Euphorbia species have been heavily studied and a high diversity of 
compounds have been isolated, many of them exhibiting important biological activities, such 
as anti-tumour, anti-malarial, cytotoxic, anti-microbial and anti-oxidant activities [9-12]. 
Particularly, they have afforded a large number of macrocyclic diterpenes possessing the 
structurally-unique lathyrane and jatrophane skeletons. These compounds share the existence 
of a very flexible macrocyclic ring and the presence of several acylating groups, which make 
them promising modulators for multidrug resistance in tumour cells [13, 14]. 
Apart from their medicinal purposes, several Euphorbia species have also shown great 
economic importance. Some of them are used as decorative pieces for their bright coloured 
leaves and flowers. Species like E. pulcherrima Willdt, commonly known as poinsettia, and E. 
milli or Christ’s thorn, which are cultivated and used as decoration during Christmas time, and 
E. resinifera which is a popular house plant in European countries [7]. 
 
1.2. Euphorbia boetica and Euphorbia pubescens 
 
Euphorbia boetica Boiss. and Euphorbia pubescens Vahl are the two species studied in 
this work. Euphorbia boetica is an herb endemic to Europe and widespread in the southern 
regions of Portugal [15]. It usually grows in pine woods or on acid soils at a very low altitude 
(0-100 meters) and flowering usually occurs in early spring. It is noteworthy that this species 
is considered endangered in some areas [16]. 
 
Euphorbia pubescens Vahl, also known as Euphorbia hirsuta L. (Figure 1) or by its 
common names hairy spurge or ésula-lanosa, is an herb endemic to the Mediterranean regions 
usually growing near river banks and streams and found at altitudes up to 1500 meters [17, 18]. 
  Introduction 
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The shrub grows between 30 to 60 cm high and its leaves are covered with small hairs on the 
upper side of the leaf or both sides. The flowering occurs between march and august [19]. 
 
Figure 1 Aerial parts from E. pubescens (A, B, C) and E. boetica (D, E, F). Adapted from http://flora-
on.pt/index.php#/1euphorbia 
 
1.3. Terpenoids: biogenetic considerations 
 
Terpenoids are one of the most diverse family of natural compounds, widely distributed 
in nature and abundantly in higher plants, with a structural diversity associated with more than 
40.000 compounds. Plant terpenoids could be classified as primary metabolites, necessary for 
cellular function like carotenoids and sterols (photoprotection and membrane permeability, 
respectively), and secondary metabolites, not involved in growth and development functions, 
but some of them often commercially attractive as flavour and colour enhancers, agricultural 
chemicals and medicine [20, 21]. Structurally, terpenoids derive from the branched C5 carbon 
skeleton of isoprene which, depending on the number of isoprene motifs, cyclization reactions, 
rearrangement and further oxidation of the carbon skeleton, enables the enormous diversity of 
Introduction   
6 
 
structures. Therefore, terpenoids are classified as monoterpenes (C10), sesquiterpenes (C15), 
diterpenes (C20), sesterterpenes (C25) and triterpenes (C30) [21-23]. 
The biosynthetic pathway for terpenoids can be divided into two main stages: 
a) The first stage consists on the synthesis of isopentenyl diphosphate (IPP) and its 
isomer, dimethylallyl diphosphate (DMAPP) (Scheme 1); 
b) In the second stage, IPP and DMAPP are used by prenyltransferases in head-to-tail 
condensation reactions to produce geranyl diphosphate (GDP), farnesyl 
diphosphate (FDP) and geranyl geranyl diphosphate (GGDP), the parent skeletons 
for each class (Scheme 2). Thus, GDP gives rise to monoterpenes, FDP to 
sesquiterpenes and GGDP to diterpenes [22, 24]. 
Higher order of terpenoids like triterpenes, derive from squalene (C30). Squalene 
contains six isoprene units, as a result of tail-to-tail condensation of two FDP molecules. After 
the formation of GDP, FDP and GGDP, terpene synthases act to generate the different carbon 
skeletons, which in turn can suffer additional transformations such as oxidations, reductions, 
isomerizations and conjugations, producing countless different terpenoid metabolites [23]. 
As can be seen in Scheme 2, IPP and its allylic isomer DMAPP are the universal 
precursors and central intermediates for the biosynthesis of all terpenoids. IPP and DMAPP 
can be synthesized by two distinct pathways: the mevalonate (MVA) pathway and the 
methylerythritol phosphate (MEP) pathway (Scheme 1). 








Scheme 1 Biosynthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) by the 
mevalonate (MVA) pathway (mammals and plants) (A) and MEP pathway (bacteria and protozoa) (B). 
Adapted from [25-28]. 








Scheme 2 Suggested pathways for the biosynthesis of monoterpenes, sesquiterpenes and diterpenes. Adapted 
from [20]. 
  
  Introduction 
9 
 
1.3.1.  The mevalonate pathway 
 
Discovered in the 1950s in yeasts and animals, the mevalonate pathway was thought to 
be the sole source of IPP and DMAPP in all living organisms. Synthesized from two molecules 
of acetyl-CoA, mevalonic acid (branched chain C6-skeleton) undergoes phosphorylation to 
mevalonate-5-phosphate, followed by further phosphorylation and decarboxylation to form the 
essential C5-intermediates isopentenyl diphosphate (IPP) and its isomer dimethylallyl 
diphosphate (DMAPP). Later on, due to inconsistencies with this route, namely the absence 
from most bacteria, several experimental results showed that MVA pathway was much less 
prominent in secondary metabolism than the mevalonate-independent pathway via 
methylerythritol phosphate, also known as MEP pathway [27, 28]. 
 
1.3.2. The mevalonate-independent pathway via methylerythritol phosphate 
 
Known by several terminologies, including mevalonate-independent pathway, non-
mevalonate pathway, glyceraldehyde-3-phosphate/pyruvate pathway, deoxy xylulose 
phosphate pathway (DXP) or methylerythritol phosphate (MEP) pathway, this pathway was 
discovered in the 1990s, due to some experiments done in bacteria, protozoa, and plants [26, 
27]. These experiments showed a considerably higher production of IPP and DMAPP in these 
organisms through the condensation of pyruvate and D-glyceraldehyde-3-phosphate by DXP 
synthase, mainly due to the lack of some of the enzymes necessary for the classic MVA 
pathway [28]. 
The first step in the MEP pathway is the formation of 1-deoxy-D-xylulose-3-phosphate 
(DXP) by the condensation of pyruvate and D-glyceraldehyde-3-phosphate, catalysed by DXP 
synthase (Scheme 1). Later on, DXP is converted to MEP through an α-ketol rearrangement 
and a reduction, catalysed by 1-deoxy-D-xylulose-5-phosphate reductoisomerase (ispC). MEP 
is then conjugated with CTP producing 4-diphosphocytidyl-2C-methyl-D-erythritol (CDP-
ME), a reaction that is catalysed by the ispD. CDP-ME is then phosphorylated by ispE, 
affording 4-diphosphocytidyl-2C-methyl-D-erythritol-2-phosphate. This molecule is then 
converted into 2C-methyl-D-erythritol-2,4-cyclodiphosphate under release of CMP, catalysed 
by ispF. The conversion of 2C-methyl-D-erythritol-2,4-cyclodiphosphate into IPP and 
DMAPP is still uncertain, although it is known to be catalysed by two enzymes, ispG and ispH 
in E. coli and other microorganisms. These catalyse two reduction reactions into 1-hydroxy-2-
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methyl-2(E)-butenyl-4-diphosphate (not shown) and finally IPP and DMAPP [26, 27]. In 
higher plants, both MVA and MEP pathways are present. In this way, the enzymes necessary 
for the mevalonate pathway are localized in the cytosol, providing cytosolic metabolites, 
particularly triterpenoids, steroids and some sesquiterpenoids. The MEP pathway, whose 
enzymes are located in the plastid organelles, supply plastid-related metabolites such as 
monoterpenes, diterpenes and tetraterpenoids (carotenoids), prenyl-side chains of chlorophylls 
and plastoquinones. These examples provide evidence of the cooperation between the cytosolic 
and plastidial pathways, especially in the biosynthesis of stress-related metabolites [20, 21, 26-
28]. 
 
1.4. Literature Review 
1.4.1. Diterpenoids 
 
Diterpenoids constitute a vast class of isoprenoid natural products (over 12000 natural 
products) [29] derived from geranylgeranyl diphosphate (GGPP, Scheme 2). They can be found 
mainly in plants and fungi and, to a lesser extent, in marine organisms and insects. Depending 
on their skeletal type (cyclization patterns), diterpenoids can be divided into different classes, 
such as acyclic, bicyclic, tricyclic, tetracyclic or macrocyclic diterpenes [30]. 
 
1.4.1.1. Diterpenoids isolated from Euphorbia sp. 
 
In this section, a literature review regarding new diterpenes isolated from Euphorbia 
genus is presented, covering works between 2013 and 2017. In Tables 1-3, new lathyrane and 
jatrophane skeletons and their polycyclic derivatives (tigliane, myrsinane and ingenane) are 













Table 1 New diterpenes with lathyrane, jatrophane and myrsinane skeletons isolated from Euphorbia sp. (isolated 
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Table 2 (continuation) New diterpenes with lathyrane, jatrophane and myrsinane skeletons isolated from 
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Table 3 (continuation) New diterpenes with lathyrane, jatrophane and myrsinane skeletons isolated from 
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E. pseudocactus Whole plant Abietane - 82-84 [59] 
E. micractina Roots Lathyrane - 85-96 [60] 
E. antiquorum Aerial parts Ingol 
Mouse 11β-HSD1 
inhibitory activity 










































































Between 2013 and 2017, several triterpenes were also isolated from Euphorbia species. 
The triterpenes isolated in this period have the euphane (115-123), tirucallane (119, 121, 122, 
124), cycloartane (125-127) and ergostane (128) skeletons (Table 4). 
 
Table 4 New triterpenes with euphane, tirucallane, cycloartane and ergostane skeletons isolated from Euphorbia 
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2. CANCER AND MULTIDRUG RESISTANCE 
 
Cancer, malignant tumours, or neoplasms are generic terms for a group of diseases that 
can affect any part of the body. One defining feature of these diseases resides on the rapid and 
disorganized proliferation of abnormal cells, which can migrate outside their normal 
environment and invade adjoining parts of the body and/or spread to other organs, in a process 
called metastasis [65]. It is the second leading cause of death in developed countries [66] and, 
according to the World Health Organization (WHO), in 2015, 8.8 million people died from 
cancer worldwide and the number of new cases of cancer is expected to rise by 70% over the 
next 20 years [65]. Over the last few decades, a remarkable progress in prevention, detection 
and treatment of cancer has been achieved and the most common ways to treat these diseases 
lie on traditional approaches such as surgery, radiotherapy, chemotherapy and biologic therapy 
[66, 67]. 
Chemotherapy is considered the basis for cancer treatment, and sometimes the only 
feasible option. Chemotherapeutic agents are usually designed to impair cell division or to 
promote apoptosis in a non-specific way [68]. However, the resistance of cancer cells to many 
clinically used drugs is regarded as the major obstacle to therapeutic success [69]. This 
resistance can be divided in two categories: intrinsic or primary resistance, and acquired 
resistance. In the first case, drug resistance is related to the failure in response of many tumours 
to the initial chemotherapy. On the other hand, acquired resistance is related to the development 
of tumour cells capable of neutralizing the effects of chemotherapeutic agents, either by 
elimination (upregulated efflux mechanisms), decreased drug uptake, activation of DNA-
repairing mechanisms or inhibition of apoptotic mechanisms [70]. 
Multidrug resistance (MDR) can be defined as the intrinsic or acquired simultaneous 
resistance of tumour cells to multiple classes of structurally and functionally divergent drugs 
[71]. Several mechanisms can be involved in MDR, such as increased drug metabolism, target 
modification and reduced drug accumulation within the cell. However, the overexpression of 
membrane proteins which mediate the active extrusion of drugs through the cellular membrane 
is one of the most studied and several ATP-Binding Cassette (ABC) transporters are known to 
be involved [70, 72]. 
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2.1. ATP-binding Cassette (ABC) superfamily 
 
The ABC transporter superfamily is one of the largest and most broadly expressed 
families of transporter protein currently known. These proteins can be found in every living 
organism, from prokaryotes to mammals, and are responsible for the active transport of a wide 
variety of compounds across biological membranes [73]. 
The vast majority of ABC transporters require energy derived from the hydrolysis of 
ATP to ADP to export a wide variety of substrates across the cell membrane against the 
concentration gradient, ranging from small molecules such as ions, to large biomolecules, such 
as oligopeptides [74]. The most critical problem in treatment failure occurs when ABC 
transporters are overexpressed, which leads to a decrease in intracellular drug concentration 
[73, 74]. ABC proteins are expressed not only in cancer cells but also in normal tissues such as 
liver, kidney, pancreas, intestine, heart and blood-brain barrier, indicating these proteins’ 
physiological roles in protecting cells against exogenous and endogenous toxic compounds 
[75, 76]. 
In human cells, three main ABC transporter proteins are involved in MDR: P-
glycoprotein (P-gp/MDR1/ABCB1), the multidrug resistant associated protein 
(MRP1/ABCC1) and the breast cancer resistant protein (BCRP/ABCG2) [77]. 
 
 
2.1.1. The ABCB Subfamily: P-glycoprotein (P-gp) 
 
Discovered in 1976 in cancer cells expressing the MDR phenotype, P-gp was the first 
multidrug transporter reported to cause a reduced drug permeation in these cells. P-gp was 
recognized as an ATP-binding cassette transporter protein and proposed to function as an efflux 
pump, based on the presence of specific conserved sequences [78], and its overexpression is 
currently the best and most studied form of multidrug resistance [73, 77]. 
P-gp is coded in humans by the mdr1 gene, located on chromosome 7, and consists of 
170-kDa and 1280 amino acids arranged in two hydrophobic homologous halves, joined by a 
linker region, each containing six transmembrane domains and a nucleotide-binding domain 
(the ATP binding site) [79]. 
 




Figure 2 Hypothetical bidimensional representation of human P-gp. Each circle represents one amino acid 
residue, with the blue circles representing showing the positions where mutations can alter the substrate 
specificity of P-gp. circled areas represent the ATP-binding sites. Phosphorylation sites are marked as 
red circles P and the glycosylation sites are marked as yellow curvy lines. Adapted from Ambudkar et 
al. (2003) [80]. 
 
P-gp acts as an efflux pump for a large variety of structurally diverse compounds. This 
protein is capable of transporting many structurally unrelated anti-cancer agents, such as vinka 
alkaloids (vincristine and vinblastine), anthracyclines (doxorubicin and daunorubicin), 
epipodophyllotoxins (etoposide) and taxanes (paclitaxel and docetaxel) (Figure 3), as well as 
other drugs, such as HIV protease inhibitors, antibiotics, antihypertensive and antihistamine 
drugs [79, 81]. 
 




Figure 3 Chemical structure of antitumor drugs vincristine, daunorubicin, etoposide and paclitaxel. 
 
Over the years, several models have been proposed to explain the mechanism of action 
of P-gp efflux, based on kinetic and mutation experiments. Among them, the most accepted 
models are the “flippase” and “hydrophobic vacuum cleaner” models (Figure 4). In both 
models, ATP binding and hydrolysis is essential for the functioning of P-gp [82]. 
 




Figure 4 Hydrophobic vacuum cleaner (A) and flippase (B) models for P-gp function. (Adapted from: SHarom 
et al., 2014) [69]. 
 
With the “flippase” model, it is suggested that P-gp acts as a translocase or flippase. 
The amphoteric drug permeates into the lipid bilayer and, once there, interacts with the 
glycoprotein, which conducts the extrusion to the outer leaflet of the bilayer. Once in the outer 
leaflet, the substrates would then either passively diffuse into the extracellular aqueous phase 
or move back to the inner leaflet by spontaneous flip-flop [82]. 
In the “hydrophobic vacuum cleaner” model, it is suggested that P-gp recognizes the 
hydrophobic substrates that accumulate inside the lipid bilayer and translocate them through 
its central pore. The vacuum cleaner model is currently the most accepted [69]. 
 
2.2. Strategies for overcoming multidrug resistance 
 
Over the last few decades, MDR has received considerable attention. Therefore, 
multiple strategies have been proposed to overcome this problem. One of the most promising 
strategies lies on the concomitant administration of anticancer drugs with other non-toxic 
compounds capable of modulating P-gp in order to restore and maintain the cytotoxic 
concentration of anticancer agents inside cancer cells [66] and great efforts have been made to 
discover effective P-gp modulators. 
P-gp reversal can occur by several mechanisms, namely: (i) direct interaction with one 
or more binding sites of P-gp, thus blocking transport by acting as a competitive or non-
competitive inhibitor; (ii) inhibition of ATP binding and hydrolysis, and; (iii) interaction with 
membrane phospholipids and consequent modification of the lipid environment of P-gp [76, 
82, 83]. 
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A variety of compounds, either synthetic or natural in origin, have been shown to act 
as MDR-modulators and some of them have undergone clinical trials. Since the 1980s, three 
generations of P-gp inhibitors have been considered. First-generation inhibitors are compounds 
developed with specific medicinal uses that have shown some P-gp-inhibition properties. 
Compounds like verapamil, cyclosporine A, quinidine and tamoxifen (Figure 5) have shown 
to inhibit P-gp, albeit high amounts of these compounds were needed to produce modulation 
effect due to their low specificity and affinity [76]. 
 
 
Figure 5 Some examples of first-generation P-gp modulators [76]. 
 
Given the high doses of first-generation compounds needed to produce any modulatory 
effects on P-gp, which resulted in unacceptable high toxicity, these compounds were no longer 
investigated, giving rise to second- and third-generation of compounds. 
Second-generation compounds were analogues of those from first generation. They 
were researched not only to reduce the toxicity of first generation drugs but also to increase 
their affinity to P-gp. Compounds like dexverapamil, valspodar and biricodar (Figure 6) were 
less toxic but still retained some of the characteristics that made them unusable for clinical 
practice, as their affinity to P-gp was still too low and high doses were still needed to produce 
any significant inhibition. Also, some pharmacokinetic interactions were reported affecting the 
metabolism and clearance mechanism as both modulators and anticancer agents were substrates 
for CYP 3A4, leading to enhanced adverse effects from the anticancer drugs [76]. 




Figure 6 Some example of second-generation P-gp modulators [76]. 
 
Given the problems with first- and second- generations of modulators, structure-activity 
relationship (SAR) coupled with HTS and combinatorial chemistry were necessary and resulted 
in the development of third-generation P-gp modulators. These novel modulators were 
designed and synthesized in order to reverse MDR and were capable to improve the treatment 
of MDR tumours by 10-fold by having high transport affinity and low pharmacokinetic 
interactions (not metabolised by CYP 3A4 and no alterations on plasma pharmacokinetics). 
Compounds like tariquidar and zosuquidar (Figure 7) are part of this generation on P-gp 
modulators [75, 76]. Some of these compounds have undergone several clinical trials, however, 
despite all the efforts, currently there is no reversal drug clinically available. 
 




Figure 7 Molecular structure of two third-generation P-gp modulators, zosuquidar and tariquidar. 
 
Given the limitations of the synthetic third-generation P-gp inhibitors, researchers have 
turned to living organisms in order to find new potential agents. The therapeutic properties of 
plants and other living organisms were explored by Man since ancient times [1] and today, 
about 50% of modern drugs are related to natural products and most of them are derived from 
plants. Due to the wide structural variety of plant secondary metabolites, natural products have 
proven to be an undeniable source of information in drug design. 
In the search for new MDR-reversing agents from plants, in last the few decades many 
diterpenes were isolated from Euphorbia species with interesting pharmacological activities, 
particularly jatrophane- and lathyrane-type diterpenes [2, 11, 12, 43, 84]. These diterpenes have 
shown promising inhibitory activity on P-gp and emerged as a new class of MDR modulators 
[46]. Moreover, since they present a structurally-homogenous skeleton differing only in their 
acylation pattern, they have been considered ideal targets for structure-activity relationship 
studies. 
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3. AIM OF THIS WORK 
 
The main objective of this project was to search for bioactive compounds, mainly 
effective modulators of P-glycoprotein in resistant cancer cells through isolation and molecular 
derivatization of compounds found in high amounts. 
Firstly, the work was focused on continuing the phytochemical study of E. boetica and 
E. pubescens methanolic extracts that had already been initiated. Then, the molecular 
manipulation of methyl gallate, a compound isolated in large amounts, was also performed, 
aiming to obtain a small set of galloyl derivatives. Due to time constraints, the obtained 
derivatives were not tested for their biological activity, allowing for future studies to be 
performed. 
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1. PHYTOCHEMICAL STUDY of Euphorbia boetica and Euphorbia 
pubescens 
 
The phytochemical study of some fractions of E. boetica and E. pubescens aerial parts 
led to the isolation of several compounds. 
From E. boetica, were isolated seven diterpenes, including one new polycyclic 
premyrsinane-type (1) diterpene, one known polycyclic premyrsinane-type diterpene (2), two 
new tigliane-type diterpenes (3, 4) and three known macrocyclic lathyrane-type diterpenes (5, 
6, 7). A large amount of a phenolic compound (8) and a cycloartane-type triterpene (9) were 
also isolated. 
From E. pubescens one macrocyclic jatrophane diterpene polyester (10) and a 
diterpenic lactone (11) were isolated. 
 
1.1. Isolated compounds – Structural Elucidation 
1.1.1. Euphorbia boetica 




Compound 1, named euphomyrsinane A, was obtained as a white amorphous powder. 
The IR spectrum displayed characteristic absorption bands for a hydroxyl group (3486 cm-1) 
and several carbonyl groups (1700 - 1730 cm-1). The ESI-MS spectrum showed a protonated 
ion at m/z 657 [M + H]+ that, together with the NMR data (Tables 5 and 6), allowed the 
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establishment of the molecular formula C35H44O12, corresponding to fourteen degrees of 
unsaturation. 
In addition to the resonances of the ester moieties, the combined analysis of 13C-NMR 
and DEPT spectra showed the presence of twenty carbon signals corresponding to: four methyl 
groups (δC 14.0, 15.0, 25.1 and 29.6), three methylenes (δC 22.2, 42.9 and an oxygenated one 
at δC 62.9), eight methines (three oxygenated at δC 78.6, 70.7 and 69.9) and five quaternary 
carbons (δC 18.4, 47.9, two oxygenated at δC 84.2 and 85.8, and one carbonyl group at δC 
204.4). The 1H-NMR spectrum provided information regarding the presence of a benzoate (δH 
7.88, d, J = 7.8 Hz; δH 7.51, t, J = 7.35 Hz; δH 7.38, t, J = 7.65 Hz) and several acetate 
substituents. The 1H-NMR spectrum also showed the presence of oxymethine protons at δH 
4.80 (d, J = 6.3 Hz), δH 5.35 (t, J = 3.45 Hz), and δH 6.38 (d, J = 11.4 Hz). These data suggested 
that this compound has a premyrsinane skeleton [5]. Through the analysis of COSY spectrum, 
it was possible to establish two sequences of correlated protons (Figure 8). The first sequence 
(fragment A) allowed the connection of carbons 1-5 and the second sequence (fragment B) the 
linkage of carbons 7-12 (Figure 8). In order to connect the two fragments, the heteronuclear 
connectivities displayed in the HMBC spectrum were utilized. In this way, the 3JC-H between 
the quaternary carbon C-14 (δC 204.4) and protons H-1β (δH 3.17, dd, J = 13.5 and 7.5 Hz) and 
H-4 (δH 2.36, dd, J = 11.4 and 3.9 Hz), and C-15 (δC 84.2) with H-3 (δH 5.35, t, J = 3.4 Hz), 
allowed the establishment of the cyclopentane ring A. Moreover, 3JC-H correlations between 
carbon C-12 (δC 35.1), the oxymethine proton H-7 (δH 4.80) and the methylene proton H-17α 
(δH 4.33, d, J = 11.7 Hz) were also observed and together with the 2JC-H correlation between 
the quaternary carbon C-6 (δC 47.9) and the methine proton H-12 (δH 3.51, d, J = 6.3 Hz) 
confirmed the existence of the six-membered ring. The gem-dimethyl cyclopropane ring, was 
supported by the high field chemical shift of the quaternary carbon C-10 (δC 18.4) and the 2JC-
H between this carbon and methyl groups at δH 0.94 and δH 1.06 (C-18 and C-19). On the other 
hand, the HMBC spectrum was also used to locate the acyl substituents. Therefore, the 
correlation of the carbonyl signal at δC 165.3 with the proton signal at δH 6.38 (H-5) indicated 
the presence of the benzoyl group at C-5. Similarly, the three acetyl esters could be assigned 
to C-3, C-7 and C-17 due to the long-range correlations between the carbonyl carbons (δC 
170.9, 170.6 and 170.4) with H-3, H-7 and H-17, respectively.  
The third acetyl group could be located either at the quaternary carbons C-13 or C-15. 
The location at C-13 was made on the basis of the observed differences between the C-13 
chemical shift (δC 82.8) of a similar diterpene already published in the literature, which has an 
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hydroxyl group at this position [15]. In fact, a downfield chemical shift of about 3.0 ppm was 
observed for compound 1, suggesting that the acetyl group could be located at this carbon.  
The relative stereochemistry of compound 1 was deduced from comparison of its 
coupling constants values to those of similar compounds and confirmed by the analysis of the 
NOESY spectrum [15]. In this way, assuming the α-orientation for H-4 based on biogenetic 
reasons [85], the strong NOE cross-peaks between H-4/H-3, H-4/H-2, H-4/H-17α, H-4/H-20 
and H-20/H-11 indicated that these protons were on the same side of the molecule. The strong 
NOE cross-peaks observed between H-5/H-12 results in the β-orientation for H-5 and H-12.  
All the above data are in agreement with structure 1, corresponding to a new polycyclic 
diterpene. 
 
Table 5 NMR data of compound 1 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
1α 3.14 dd (13.5; 7.5) 
42.9 CH2 3, 16 
1β 1.65 s 
2 1.84 m 37.3 CH 16 
3 5.35 t (3.45) 78.6 CH 1β, 16 
4 2.39 dd (11.6; 3.9) 50.3 CH 1β, 5 
5 6.38 d (11.4) 69.9 CH 4, 17α 
6 - - 47.9 C 
7, 8α, 12, 17α, 
17β 
7 4.80 d (6.3) 70.7 CH 5, 8α, 17β 
8α 2.13 m 
22.2 CH2 - 
8β 1.80 m 
9 0.74 d (1.8) 19.0 CH - 
10 - - 18.4 C 8β, 9, 12, 18, 19 
11 0.72 d (3.3) 24.0 CH 11, 18, 19 
12 3.51 d (6.3) 35.1 CH 7, 20 
13 - - 85.8 C 12, 20 
14 - - 204.4 C 1α, 1β, 4, 20 
15 - - 84.2 C 3, 20 
16 0.87 d (6.6) 14.0 CH3 1α, 1β, 4, 20 
17α 4.71 d (11.7) 
62.9 CH2 5 
17β 4.33 d (11.7) 
18 0.94 s 15.0 CH3 9, 11, 19 
19 1.05 s 29.6 CH3 9, 11, 18 
20 1.71 s 25.1 CH3 - 
3-OAc 
- - 170.9 C 3 
2.12 s 21.4 CH3 - 
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Table 6 (continuation) NMR data of compound 1 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
5-OBz 
- - 165.3 C 5 
- - 129.7 C 3', 5' 
7.88 d (7.8) 129.9 CH 3', 4', 5' 
7.38 t (7.65) 128.4 CH 2', 6' 
7.51 t (7.35) 133.2 CH 2', 6' 
7-OAc 
- - 170.6 C 7, 8β 
1.95 s 21.1 CH3 - 
13-OAc 
- - 170.9 C 20 
1.46 s 20.6 CH3 - 
17-OAc 
- - 170.4 C 17β 
2.16 s 21.5 CH3 - 
 
 
Figure 8 1H-spin systems of compound 1 assigned by HMQC and 1H-1H COSY (fragments A and B, in green and 
red, respectively) and their connection by the main 2JC-H and 3JC-H correlations displayed in the HMBC 
spectrum () 
  







Compound 2 was isolated as a white powder. Its IR spectrum displayed absorption 
bands for carbonyl groups (1700 - 1739 cm-1) and for a hydroxyl group (3487 cm-1). The ESI-
MS spectrum exhibited a protonated molecule at m/z 671 [M + H]+ that, together with the NMR 
data, allowed the establishment of the molecular formula C36H46O12, from which fourteen 
degrees of unsaturation were deduced. The spectroscopic data of compound 2 were very similar 
to compound 1 pointing also to the existence of a premysinane skeleton. 
The 1H-NMR spectrum (Table 7) showed signals for three tertiary methyls (displayed 
as singlets at δH 0.93, 1.04 and 1.70), one secondary methyl group at δH 0.84 (d, J = 6.3 Hz), 
one diastereotopic oxymethylene group at δH 4.29 (d, J = 11.4 Hz; 4.68 d, J = 11.7 Hz) and 
three oxymethine protons (δH 4.78 d, J = 6.6 Hz; δH 5.36 t, J = 3.3 Hz; 6.36 d, J = 11.4 Hz). 
In addition, several signals corresponding to acyl groups were also observed, namely, one 
benzoate (δH 7.86, d, J = 7.8 Hz; δH 7.49, t, J = 7.35 Hz; δH 7.35, t, J = 7.65 Hz), one propanoate 
(δH 2.26, q, J = 7.5 Hz; δH 0.94, t, J = 7.5 Hz) and three acetyl groups suggested by the presence 
of three methyl singlets at δH 1.46, 2.10 and 2.14.  
Besides the signals due to the ester functions, the 13C-NMR spectrum (Table 7) 
exhibited twenty-carbon resonances, that were discriminated by a DEPT experiment as four 
methyl groups, three methylenes (one oxygenated at δC 62.9), eight methines (three oxygenated 
at δC 78.2, 70.7 and 69.9), four quaternary carbons (two oxygenated at δC 85.8 and 84.2) and a 
carbonyl group at δC 204.4). The unambiguous assignment of all proton and carbon resonances 
was possible through the combined analysis of 2D-NMR spectra, namely COSY, HMQC and 
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HMBC. In particular, 1H-1H-COSY and HMQC spectra defined two structural fragments with 
correlated protons (fragments A and B, Figure 9). The linkage of these fragments was possible 
through the 2JC-H and 3JC-H correlations displayed in the HMBC spectrum, namely, those 
between the quaternary carbon C-14 and H-1α, H-1β, H-4, H-12 and H-20 in addition to those 
found between C-13 and H-11, H-12 and H-20. These correlations locate the carbonyl group 
at C-14 and build up the cyclopentane ring. Moreover, the heteronuclear 2JC-H and 3JC-H 
correlations allowed the assignment of the cyclohexane ring, which was established due to the 
observed correlations between C-6 and H-7, H-17 and H-12, along with those found between 
C-7 and H-12 and H-17, and C-12 and H-17 (Figure 9).  
Analysis of HMBC spectrum also allowed the location of the ester groups. Accordingly, 
the correlations of the carbonyl signals at δC 165.2 and 173.6 with the oxymethine protons H-
5 (δH 6.36) and H-3 (δH 5.36), respectively, indicated the presence of the benzoyl and propanoyl 
groups at these carbons. Similarly, two acetyl esters could be undoubtedly assigned to carbons 
C-7 and C-17 due to the observed long-range correlations between the carbonyl carbons and 
the proton signals at δH 4.78, δH 4.29 and δH 4.68. The position of the remaining acetyl group 
could not be established based on the HMBC correlations, since it should be located at C-13 or 
C-15 that are quaternary carbons. Thus, the position of this acetyl group was assigned to C-13, 
regarding the chemical shift differences between compound 2 (δC 85.8) and that of a similar 
diterpene already published in the literature (δC 82.8), which has a hydroxyl group at this 
position [15]. In fact, a downfield chemical shift of about 3.0 ppm was observed for compound 
2, suggesting that the acetyl group could be located at C-13.  
The relative configuration of compound 2 was deduced through the analysis of a 
NOESY spectrum and by comparison of the coupling constant values with those reported in 
the literature [85]. In this way, assuming the α-orientation for H-4 based on biogenetic reasons, 
the strong NOE cross-peaks between H-4/H-3, H-4/H-2, H-4/H-17α, H-4/H-20 and H-20/H-11 
indicated that these protons were on the same side of the molecule. The strong NOE cross-
peaks observed between H-5/H-12 results in the β-orientation for H-5 and H-12. 
All the above data are in agreement with those reported in the literature [86] allowing 
for the identification of compound 2 as an already known premyrsinane-type diterpene, 
premyrsinol-3-propanoate-5-benzoate-7,13,17-triacetate that differs from compound 1 by the 
presence of a propanoyl instead of an acetyl group at C-3. 
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Table 7 NMR data of compound 2 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz) 
Position 1H (J in Hz) 13C DEPT HMBC 
1α 3.14 dd (13.5; 7.5) 
42.9 CH2 3, 16 
1β 1.63 m 
2 1.85 m 37.3 CH 1, 16 
3 5.36 t (3.3) 78.2 CH 1, 16 
4 2.39 dd (9.8; 3.9) 50.3 CH 1, 5 
5 6.36 d (11.4) 69.9 CH 4, 17 
6 - - 47.8 C 7, 8, 12, 17 
7 4.78 d (6.6) 70.7 CH 5, 8, 9, 17 
8α 2.14 m 
22.1 CH2 - 
8β 1.86 m 
9 0.73 br s 18.9 CH 7, 11 
10 - - 18.4 C 11, 18, 19 
11 0.71 d (3.2) 23.9 CH 1, 3, 12 
12 3.50 d (6.6) 35.1 CH 17, 20 
13 - - 85.8 C 11, 12, 20 
14 - - 204.4 C 1, 4, 20 
15 - - 84.2 C 1, 3, 5 
16 0.84 d (6.3) 13.9 CH3 - 
17α 4.68 d (11.4) 
62.9 CH2 5 
17β 4.29 d (11.4) 
18 0.93 s 14.9 CH3 11, 19 
19 1.04 s 29.5 CH3 9, 18 
20 1.70 s 25.0 CH3 - 
3-OPr 
- - 173.6 C 3 
2.26 q (7.5) 27.6 CH2 - 
0.94 t (7.5) 8.8 CH3 - 
5-OBz 
- - 165.2 C 5 
- - 129.9 C - 
7.86 d (7.8) 129.7 CH - 
7.35 t (7.65) 128.3 CH - 
7.49 t (7.35) 133.1 CH - 
7-OAc 
- - 170.8 CH2 - 
1.45 s 20.6 CH3 - 
13-OAc 
- - 170.8 C - 
2.1 s 21.5 CH3 - 
17-OAc 
- - 170.3 C 17 
2.14 s 21.4 CH3 - 




Figure 9 1H-spin systems of compound 2 assigned by HMQC and 1H-1H COSY (fragments A and B, in green 
and red, respectively) and their connection by the main 2JC-H and 3JC-H correlations displayed in the 
HMBC spectrum (). 
 




Compound 3, named phorboboetirane A, was isolated as white crystals (m.p. 190 oC). 
Its IR spectrum displayed absorption bands for hydroxyl group (3303 cm-1) and carbonyl 
groups (1699 - 1757 cm-1). The ESI-MS spectrum exhibited a protonated molecule at m/z 517 
[M + H]+ that, together with the NMR data, allowed the establishment of the molecular formula 
C30H44O7, from which nine degrees of unsaturation were deduced.  
The 1H-NMR spectrum (Tables 8 and 9) showed signals for two tertiary methyls 
(displayed as singlets at δH 1.18 and 1.20), one secondary methyl group at δH 1.09 (d, J = 6.3 
Hz), and two vinylic methyl groups at δH 1.80 (s) and 1.89 (t, J = 1.5 Hz). Signals 
corresponding to two oxymethine protons (δH 4.44 d, J = 4.5 Hz; 5.47 m) and two olefinic 
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protons at δH 4.85 (br s) and 7.04 (s), were also observed. From this spectrum two ester residues 
were identified, namely an isobutyryl (δH 2.55 m, δH 1.15 d, J = 4.5 Hz, δH 1.17 d, J = 6.8 Hz) 
and a 2,3-dimethylbutyryl group (δH 2.22 m; δH 1.89 m; δH 1.14 d, J = 4.5 Hz, δH 0.98 d, J = 
6.9 Hz and δH 0.96 d, J = 6.9 Hz).  
Additionally, to the signals due to the ester functions, the 13C-NMR spectrum (Tables 
8 and 9) exhibited twenty carbon resonances, that were discriminated by a DEPT experiment 
as five methyl groups, nine methines (two olefinic at δC 125.6 and 154.8 and two oxygenated 
at δC 71.0 and 74.1), and six quaternary carbons (two oxygenated at δC 64.9 and 78.5, two sp2 
carbons at δC 137.7 and 144.1 and a carbonyl group at δC 207.7). The high-field carbonyl signal 
at δC 207.7, together with the olefinic proton at δH 7.04 (δC 154.8), confirmed the presence of 
an α,β-unsaturated ketone. On the other hand, the high field quaternary carbon at δC 25.4, 
pointed out the existence of a gem-dimethyl-cyclopropane ring. Based on all these data, a 
tigliane-type diterpene skeleton was proposed for compound 3. The unambiguous assignment 
of the all proton and carbon resonances was possible through the combined analysis of 2D-
NMR spectra, namely COSY, HMQC and HMBC (Figure 10).  
In particular, 1H-1H-COSY and HMQC spectra defined four structural fragments with 
correlated protons (Figure 10), which were separated by quaternary carbons (fragments A – 
D). The linkage of these fragments was possible through the 2JC-H and 3JC-H correlations 
displayed in the HMBC spectrum, namely, those between C-3 and H-1, H-4 and H-19 which 
located the carbonyl group and build up the cyclopentene ring. The connection of fragments A 
and B was possible due to the observed cross-peaks between C-6 and H-4, and C-5 and H-7 
and H-20. On the other hand, the correlation between C-7 and H-14 established the linkage 
between the fragments B and C. The correlations between C-13 and H-12, H-14 and H-17 
together with those found between C-15 and H-12, H-14, H-15 and H-16 allowed the 
establishment of the cyclopropane ring and the linkage between fragments D and C. 
Heteronuclear 2JC-H and 3JC-H correlations between C-9 with H-4, H- 11 and H-18 established 
the linkage of fragments A and D. Finally, the correlation between C-9 and H-7 confirmed the 
linkage between C-8 and C-9, proving the existence of a four-ring skeleton (Figure 10).  
The ester substituents were also allocated by the combined analysis of 2D-NMR 
spectra. Thus, the assignment of the 2,3-dimethylbutanoate ester at C-12 was deduced by the 
existence of a HMBC cross-peak between the carbonyl signal at δC 175.8 and the oxymethine 
proton at δH 5.47 (H-12). The assignment of the isobutyrate group at C-13 could not be done 
through the HMBC spectrum since it is a quaternary carbon. Thus, the location of this ester 
group was established regarding the information obtain in the literature for similar compounds 
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[87, 88]. The relative configuration of compound 3 was deduced through the analysis of a 
NOESY spectrum and by comparison of the coupling constant values with those reported in 
the literature [89]. Accordingly, the majority of 4-deoxyphorbol diterpenes isolated to date 
have β- and α- configurations for H-4 and H-10, possessing, therefore an A/B trans-ring 
junction [87, 88, 90]. However, some differences were observed on the chemical shifts, 
multiplicity and coupling constants of compound 3, when compared to those diterpenes. The 
main differences were the signal resonance for H-1 that was shifted upfield in compound 3 (δH 
7.04) instead of c.a 7.57 [87, 88], and the multiplicity and coupling constants of H-4 that 
appeared at δH 3.12 (dd, J = 6.6 and 4.5 Hz), differing from those observed for H-4β tigliane 
diterpenes (dd, J = 10.9 and 4.5 Hz) [91]. The 13C NMR also showed some significant chemical 
shift differences, namely in carbons C-1, C-2 and C-3 that were shifted upfield, and C-4 that 
was shifted downfield. Moreover, NOE cross-peaks between H-4/H-10, H-4/H-5 and CH3-
18/H-12 indicated that these protons had the same orientation (α). On the other hand, the 
correlations between H-11/H-8 and H-8/CH3-17 suggested that these protons were β-
orientation. The absence of correlation between H-4 and H-8 confirmed the α arrangement for 
H-4 and β arrangement for H-8. 
 
Table 8 NMR data of compound 3 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
1 7.04 s 154.8 CH 10, 19 
2 - - 144.1 C 19 
3 - - 207.7 C 1, 4, 19 
4 3.12 dd (6.6; 4.5) 56.2 CH - 
5 4.44 d (4.5) 71.0 CH 4, 7, 20 
6 - - 137.7 C 4, 20 
7 4.85 br s 125.6 CH 14, 20 
8 1.99 m 40.2 CH - 
9 - - 78.5 C 4, 7, 11, 18 
10 3.62 m 47.9 CH 4 
11 1.70 m 43.1 CH 12, 18 
12 5.47 m 74.1 CH 14, 18 
13 - - 64.9 C 12, 14, 16, 17 
14 0.76 d (4.8) 38.1 CH 7, 16, 17 
15 - - 25.5 C 12, 14, 16, 17 
16 1.20 s 16.6 CH3 17 
17 1.18 s 24.9 CH3 16 
18 1.09 d (6.3) 11.8 CH3 12 
19 1.80 s 10.6 CH3 - 
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Table 9 (continuation) NMR data of compound 3 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
20 1.89 t (1.5) 27.3 CH3 7 
12-O(2,3-dMB) 
- - 175.8 C 12 
2.22 m 47.4 CH - 
1.89 m 31.3 CH - 
0.98 d (6.9) 20.9 CH3 - 
0.96 d (6.9) 19.5 CH3 - 
1.14 d (4.5) 18.6 CH3 - 
13-OiBu 
- - 179.4 C - 
2.55 m 34.4 CH - 
1.15 d (4.5) 18.6 CH3 - 
1.17 d (6.8) 14.7 CH3 - 
 
 
Figure 10 1H-spin systems of compound 3 assigned by HMQC and 1H-1H COSY (-) and their connection by the 
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Compound 4, named phorboboetirane B, was isolated as an oil. The 1H-NMR spectrum 
(Tables 10 and 11) showed signals for two tertiary methyls at δH 1.23 and 1.33 (both displayed 
as singlets), one secondary methyl group at δH 1.00 (d, J = 6.4 Hz), and two vinylic methyl 
groups at δH 1.62 (dd, J = 2.5, 1.3 Hz) and 1.75 (s). Signals corresponding to two oxymethine 
protons at δH 6.48 (d, J = 3.7) and 5.66 (d, J = 9.6) and two olefinic protons at δH 5.48 (d, J = 
4.9) and δH 7.72 (br s) were also observed. From this spectrum, three esters residues were 
identified, namely, one isobutyryl (δH 2.63 p, J = 7.0; δH 1.21 d, J = 3.4; δH 1.18, s) and two 
benzoyl (one at δH 7.58, m; δH 7.48, m; δH 8.01, m; and another one δH 7.84, d, J = 1.5 Hz; δH 
7.38, t, J = 7.6; and δH 7.52, t, J = 2.0). 
Additionally to the signals due to the esters functions, the 13C-NMR spectrum (Tables 
10 and 11) exhibited twenty-carbon resonances, discriminated by DEPT as five methyl groups, 
nine methines (two olefinic at δC 130.0 and 161.0 and two oxygenated at δC 73.8 and 77.7) and 
six quaternary carbons (two oxygenated at δC 65.2 and 78.9; two sp2 carbons at δC 138.0 and 
138.4; and a carbonyl group at δC 205.5). The high-field carbonyl group signal at δC 205.5 
coupled with the olefinic proton at δH 7.72 (δC 161.0), confirmed the presence of an α,β-
unsaturated ketone. On the other hand, the high-field quaternary carbon at δC 26.5 suggested 
the existence of a gem-dimethyl-cyclopropane ring. Based on all this data, a tigliane-type 
diterpene skeleton was proposed for compound 4, similar to that of compound 3. The 
unambiguous assignment of all the proton and carbon resonances was possible through the 
combined analysis of 2D-NMR spectra, such as COSY, HMQC and HMBC (Figure 11). 
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In particular, 1H-1H COSY and HMQC spectra defined four structural fragments with 
correlated protons (fragments A-D, Figure 11). The linkage of these fragments was possible 
through the 2JC-H and 3JC-H correlations displayed in the HMBC spectrum, namely, those 
between C-3 and H-1 and H-4 which located the carbonyl group and build up the cyclopentene 
ring. Additionally, the connection of fragments A and B was possible due to the observed cross-
peaks between C-5 and H-7 and H- 20. On the other hand, the correlation between C-7 and H-
14 established the linkage between the fragments B and C. The correlations between C-13 and 
H-12, H-14, H-16, H-17 and H-18 together with those found between C-15 and H-12, H-14, 
H-16 and H-17 allowed the establishment of the cyclopropane ring and the linkage between 
fragments D and C. Heteronuclear 2JC-H and 3JC-H correlations between C-9 with H-4 and H-18 
established the linkage of fragments A and D.  
The combined analysis of 2D-NMR spectra also located the position of the ester 
substituents. The assignment of one of the benzoyl groups was deduced by the existence of a 
HMBC cross-peak between the carbonyl group at δC 166.1 and the oxymethine proton at δH 
5.66 (H-12) [92]. The second benzoyl group was assigned to C-5 due to the HMBC cross-peak 
between the carbonyl group at δC 165.40 and the oxymethine proton at δH 6.48 (H-5). Similar 
to the previous compound, the assignment of the isobutyrate group at C-13 could not be 
accomplished through the HMBC spectrum since it is a quaternary carbon. Thus, the location 
of this ester group was established regarding the information obtained in the literature for 
similar compounds [87, 88]. 
 
Table 10 NMR data of compound 4 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
1 7.72 br s 161.0 CH - 
2 - - 138.0 C 1 
3 - - 205.5 C 1, 4 
4 2.81 t (4.4) 49.3 CH 1 
5 6.48 d (3.7) 73.8 CH 7, 20 
6 - - 138.4 C 5, 11, 20 
7 5.48 d (4.9) 130.0 CH 14, 20 
8 2.46 br s 42.6 CH 7, 12, 18 
9 - - 78.9 C 4, 18 
10 3.81 m 52.6 CH 1, 4, 5 
11 1.70 d (3.1) 43.2 CH 12, 18 
12 5.66 d (9.6) 77.7 CH 4, 11, 18 
13 - - 65.2 C 
12, 14, 16, 17, 
18 
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Table 11 (continuation) NMR data of compound 4 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
14 1.10 d (1.6) 36.8 CH 7, 16, 17 
15 - - 26.5 C 12, 14, 16, 17 
16 1.23 s 23.8 CH3 14, 17 
17 1.33 s 17.2 CH3 14, 16 
18 1.00 d (6.4) 15.5 CH3 12 
19 1.62 dd (2.5; 1.3) 10.2 CH3 - 
20 1.75 s 21.7 CH3 7 
5-OBz 
- - 165.4 C 5 
- - 130.1 C - 
7.84 d (1.5) 129.8 CH - 
7.38 t (7.6) 128.4 CH - 
7.52 t (2.0) 133.4 CH - 
12-OBz 
- - 166.1 C 12 
- - 130.1 C - 
8.01 m 129.8 CH - 
7.48 m 128.7 CH - 
7.58 m 133.1 CH - 
13-OiBu 
- - 179.6 C - 
2.63 m 34.4 CH - 
1.21 d (3.4) 18.7 CH3 - 
1.18 s 18.8 CH3 - 
 
 
Figure 11 1H-spin systems of compound 4 assigned by HMQC and 1H-1H COSY (-) and their connection by the 
main 2JC-H and 3JC-H correlations displayed in the HMBC spectrum () 
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Compound 5 was obtained as a white powder. The IR spectrum displayed characteristic 
absorption bands for an α,β-unsaturated ketone (1644 cm-1) and ester carbonyl groups (1736 
cm-1). The ESI-MS spectrum showed a protonated ion at m/z 461 [M + H]+. The data obtained 
from the 1H-NMR and 13C-NMR spectra (Table 12) showed that this compound has a lathyrane 
scaffold. The 13C-NMR and DEPT spectra confirmed the existence of five quaternary carbons 
(two olefinic at δC 144.5 and 134.3, one oxygenated at δC 92.4 and one carbonylic at δC 197.0), 
seven methines (one olefinic at δC 146.9 and two oxygenated at δC 80.3 and 65.9), four 
methylenes (δC 21.7, 35.1, 48.4 and one exocyclic methylene at δC 115.7) and four methyl 
groups. Furthermore, three acetate groups were also observed (Table 12).  
The combined analysis of HMQC and 1H-1H-COSY spectra provided the data that 
allowed the establishment of two fragments of correlated protons (Figure 12) that were 
connected by the analysis of the long-range correlations (2JC-H and 3JC-H) provided by HMBC 
spectrum. Accordingly, the cross-peaks observed between the quaternary carbon C-15 (δC 92.4) 
and protons H-1α and H-4 allowed the establishment of the cyclopentane ring. The observed 
long-range correlations between the quaternary carbon C-6 (δC 144.5) and the protons H-5, H-
8α and H-17α allowed the connection of the two fragments with the exocyclic double bond. 
The complete linkage of the fragments followed from the observed 3JC-H correlations of the 
carbonyl group at C-14 (δC 197.0) with H-1β and CH3-20 (Figure 5). Finally, the long-range 
interaction between the carbons C-9 (δC 35.5) and C-11 (δC 28.5) and the protons H-18 (δH 
1.12, s) and H-19 (δH 1.14, s) confirmed the existence of the cyclopropane ring. The relative 
configuration of compound 5 was deduced from the analysis of coupling constant values and a 
NOESY spectrum, assuming α orientation for H-4 and was found to be identical to other ∆6,17-
lathyrane diterpenes isolated to date [93]. All data described above was in agreement with those 
reported in the literature allowing the identification of compound 5 as euphoboetirane A  [93]. 
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Table 12 NMR data of compound 5 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
1α 1.56 dd (15.75; 8.7) 
48.4 CH2 3, 16 
1β 3.42 dd (12.3; 7.8) 
2 2.24 m 37.3 CH 1α, 1β, 16 
3 5.53 t (3.75) 80.3 CH 1β, 16 
4 2.72 dd (7.65; 2.55) 52.3 CH 5 
5 6.04 d (7.8) 65.9 CH 4, 17α, 17β 
6 - - 144.5 C 5, 8α, 17α 
7α 1.11 m 
35.1 CH2 5, 17α, 17β 
7β 2.20 m 
8α 1.69 d (5.1) 
21.7 CH2 7β 
8β 2.07 s 
9 1.14 m 35.5 CH 18, 19 
10 - - 25.4 C 18, 19 
11 1.38 dd (8.7; 6.3) 28.5 CH 18, 19 
12 6.49 dd (11.4; 1.2) 146.9 CH - 
13 - - 134.3 C 11, 20 
14 - - 197.0 C 1β, 4, 12, 20 
15 - - 92.4 C 1α, 3, 5 
16 0.88 d (5.1) 14.2 CH3 1α 
17α 4.70 s 
115.7 CH2 5 
17β 4.97 s 
18 1.12 s 16.9 CH3 9, 11, 19 
19 1.14 s 29.1 CH3 9, 18 
20 1.66 m 12.6 CH3 12 
3-OAc 
- - 170.9 C 3 
2.02 s 21.4 CH3 - 
5-OAc 
- - 170.7 C 5 
1.96 s 21.0 CH3 - 
15-OAc 
- - 170.0 C - 
2.09 s 22.1 CH3 - 
 
 
Figure 12  1H-spin systems of compound 5 assigned by HMQC and 1H-1H COSY (-) and their connection by 
the main 2JC-H and 3JC-H correlations displayed in the HMBC spectrum () 
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Compound 6 was isolated and identified as epoxyboetirane A. The IR spectrum 
displayed absorption bands for ester functions (1736 and 1256 cm-1) and for an α,β-unsaturated 
ketone (1671 cm-1). The ESI-MS spectrum exhibited a protonated molecule at m/z 477 [M + 
H]+ that, together with the NMR data, allowed the establishment of the molecular formula 
C26H36O8, from which nine degrees of unsaturation were deduced.  
The 1H-NMR spectrum (Table 13) showed signals for two tertiary methyls (both 
displayed as singlets at δH 1.18), one secondary methyl group at δH 0.85 (d, J = 6.7 Hz), one 
vinylic methyl group at δH 1.83 (s) and three downfield singlets (δH 2.00, 2.06 and 2.08) that 
suggested the presence of three acetyl groups. Signals corresponding to two oxymethine 
protons (δH 5.44 t, J = 3.1 Hz; 6.19 d, J = 9.3 Hz), one diastereotopic oxymethylene group (δH 
2.29 br s; 2.46 d, J = 3.4 Hz) and one olefinic proton at δH 6.57 (d, J = 11.4 Hz), were also 
observed.  
Besides the signals due to the ester functions, the 13C-NMR spectrum (Table 13) 
exhibited twenty carbon resonances, that were discriminated by a DEPT experiment as four 
methyl groups, four methylenes (one oxygenated at δC 55.4), seven methines (one olefinic at 
δC 143.9 and two oxygenated at δC 80.4 and 65.3), and five quaternary carbons (two oxygenated 
at δC 59.0 and 91.9, one sp2 carbon at δC 136.1 and a carbonyl group at δC 197.0). The high-
field carbonyl signal at δC 197.0 together with the olefinic proton at δH 6.57 (δC 143.9) 
confirmed the presence of an α,β-unsaturated ketone. On the other hand, the high field 
quaternary carbon at δC 25.7, pointed out to the existence of a gem-dimethyl-cyclopropane ring. 
Based on all these data, a lathyrane-type diterpene skeleton was proposed for compound 6. The 
unambiguous assignment of the all proton and carbon resonances was possible through the 
combined analysis of 2D-NMR spectra, namely COSY, HMQC and HMBC.  
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In particular, 1H-1H-COSY and HMQC spectra defined two structural fragments with 
correlated protons (Figure 6), which are separated by quaternary carbons. The linkage of these 
fragments was possible through the 2JC-H and 3JC-H correlations displayed in the HMBC 
spectrum, namely those between C-14 and H-1α, H-1β, H- 4 and H-20, which locate the 
carbonyl group at C-14 and build up the cyclopentane ring. Moreover, the heteronuclear 2JC-H 
and 3JC-H correlations allowed the assignment of an epoxy ring at C-6/C- 17, which was 
connected to the two fragments due to the observed correlations between C-5 (δC 65.3) and C-
7 (δC 33.6) with CH2-17. Analysis of HMBC spectrum also allowed the location of the acetyl 
groups at C-3 and C-5. The lack of 3JC-H correlations between the carbonyl carbon at δC 170.7 
and oxymethine protons allowed the assignment of the third acetyl group at C-15. The location 
of this third acetyl group was also corroborated by the downfield chemical shift of C-15 [13].  
The relative configuration of compound 6 was deduced through the analysis of a 
NOESY spectrum and by comparison of the coupling constant values with those reported in 
the literature for epoxyboetirane A [13]. 
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Table 13 NMR data of compound 6 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
1α 3.38 dd (14.4; 8.4) 
48.0 CH2 3, 16 
1β 1.48 m 
2 2.10 m 37.6 CH 1, 16 
3 5.44 t (3.4) 80.4 CH 1, 16 
4 1.86 dd (9.2; 3.6) 50.1 CH 1α, 5 
5 6.19 t (9.3) 65.3 CH 4, 7, 17 
6 - - 59.0 C 4, 5, 7, 17 
7α 0.90 m 
33.6 CH2 5, 17 
7β 2.11 m 
8 1.70 m 20.1 CH2 - 
9 1.07 m 34.3 CH 11, 18, 19 
10 - - 25.7 C 11, 18, 19 
11 1.46 m 29.1 CH 9, 18, 19 
12 6.57 d (11.6) 143.9 CH 20 
13 - - 136.1 C 11, 20 
14 - - 197.0 C 1, 4, 12 
15 - - 91.9 C 1, 3, 5 
16 0.85 d (6.4) 14.1 CH3 - 
17α 2.29 br s 
55.4 CH2 - 
17β 2.46 d (3.4) 
18 1.18 s 29.0 CH3 11, 19 
19 1.18 s 16.8 CH3 18 
20 1.83 s 12.5 CH3 - 
3-OAc 
- - 170.4 C 3 
2.00 s 20.9 CH3 - 
5-OAc 
- - 170.7 C 5 
2.06 s 21.1 CH3 - 
15-OAc 
- - 165.9 C - 
2.08 s 22.0 CH3 - 
 
 
Figure 13 1H- spin systems of compound 6 assigned by HMQC and 1H-1H COSY (-) and their connection by the 
main 2JC-H and 3JC-H correlations displayed in the HMBC spectrum () 
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Compound 7 was obtained as white crystals (m.p. 205 oC). The IR spectrum displayed 
absorption bands for ester carbonyl groups (1738 cm-1) and α,β-unsaturated ketone (1652 cm-
1). The data obtained from the 1H-NMR and 13C-NMR spectra (Table 14) suggested that the 
compound is a macrocyclic diterpene with the lathyrane scaffold similar to compound 6 [13]. 
The 13C-NMR and DEPT spectra confirmed the existence of four methylenes (δC 20.1, 337.0 
and 48.1 and one oxygenated at δC 55.6) and five quaternary carbons (of which two oxygenated 
at δC 59.0 and 91.9, one olefinic at δC 136.1 and one carbonyl group at δC 197.0). The 1H-NMR 
spectrum established the existence of two oxymethine protons δH 5.48 (t, J = 3.2 Hz) and δH 
6.17 (d, J = 9.2 Hz) and one olefinic proton δH 6.56 (d, J = 11.6 Hz).  
The analysis of spectroscopic data led to the conclusion that compounds 6 and 7 were 
rather similar. The major difference resided on the presence of signals corresponding to a 
propanoyl group at C-3 in compound 7 (δH 2.29 d, J = 2.7 Hz; 1.1 t, J = 7.6 Hz and δC 173.6, 
27.8, 9.1) instead of the acetyl group in compound 6. The structure of 7 was confirmed by 1H-
1H COSY, HMQC and HMBC experiments that allowed the unequivocal assignment of all 1H 
and 13C signals. The relative stereochemistry of all tetrahedral centres was found to be identical 
to those of compound 6. From the above data, it was concluded that compound 7 was an already 
isolated diterpene named epoxyboetirane K [13, 94]. 
  
  Phytochemical Studies: Results and Discussion 
53 
 
Table 14 NMR data of compound 7 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
1α 1.50 dd (9.2; 3.6) 
48.1 CH2 3, 16 
1β 3.39 dd (11.4; 8.4) 
2 2.11 m 37.7 CH 1α, 1β, 16 
3 5.48 t (3.2) 80.2 CH 1β, 4, 16 
4 1.87 dd (11.0; 3.2) 50.1 CH 1β, 2, 5 
5 6.17 d (9.2) 65.3 CH 4, 7α, 9, 17β 
6 - - 59.0 C 
4, 5, 7α, 8α, 8β, 17α, 
17β 
7α 0.89 t (12.8) 
33.7 CH2 5, 9, 17β 
7β 2.11 m 
8α 1.69 t (6.8) 
20.1 CH2 7α, 11 
8β 2.02 m 
9 1.06 m 34.9 CH 
7α, 8α, 8β, 11, 12, 18, 
19 
10 - - 25.7 C 9, 18, 19 
11 1.46 m 29.1 CH 8β, 18, 19 
12 6.56 d (11.6) 143.9 CH 9, 20 
13 - - 136.1 C 12, 20 
14 - - 197.0 C 1α, 4, 12, 20 
15 - - 91.9 C 1α, 1β, 2, 3, 4, 5 
16 0.83 d (6.8) 14.1 CH3 1α, 1β 
17α 2.29 m 
55.6 CH2 7α 
17β 2.46 d (3.6) 
18 1.18 s 29.0 CH3 9, 11, 19 
19 1.18 s 16.8 CH3 11, 18 
20 1.82 s 12.5 CH3 12 
3-OPr 
- - 173.6 C 2', 3' 
2.29 d (2.7) 27.8 CH2 3' 
1.10 t (7.6) 9.1 CH3 2' 
5-OAc 
- - 170.7 C 5 
2.04 s 21.1 CH3 - 
15-OAc 
- - 169.8 C - 
2.07 s 21.9 CH3 - 




Figure 14 1H-spin system of compound 7 assigned by HMQC and 1H-1H COSY (-) and their connection by the 
main 2JC-H and 3JC-H correlations displayed in the HMBC spectrum () 
 




Compound 8 was isolated as white crystals (m.p. 204 oC) and identified as methyl 
gallate based on its spectroscopic data. 
The 1H-NMR spectrum exhibited two singlet signals at δH 7.03 and 3.80, which hinted 
at a very simple structure (Table 15). On the other hand, the 13C-NMR spectrum exhibited six 
carbon signals: five quaternary (one carbonyl at δC 167.6), two methines and one oxygenated 
at δC 50.9. These NMR data were consistent with those published in the literature for the methyl 
ester of 3,4,5-trihydroxybenzoic acid or methyl gallate [95, 96]. 
 
Table 15 NMR data of compound 8 (MeOD4, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 
1H 
(J in Hz) 
13C DEPT 
1 - - 126.3 C 
2 7.03 s 106.8 CH 
3 - - 153.0 C 
4 - - 142.2 C 
5 - - 153.0 C 
6 7.03 s 106.8 C 
7 - - 166.9 C 
7-OCH3 3.8 s 52.4 CH3 
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Compound 9, named 24-methylenecycloartanol, was obtained as white crystals (m.p. 
120 oC). The IR spectrum displayed absorption bands for a hydroxyl group (3371 cm-1). The 
data obtained from the 1H-NMR and 13C-NMR spectra (Tables 16 and 17) suggested that this 
compound was a cycloartane-type triterpene. 
The 1H-NMR spectrum exhibited two highly shielded doublets at δH 0.33 (d, J = 4.1 
Hz) and δH 0.55 (d, J = 4.0 Hz). The 1H-NMR spectrum also showed the presence of seven 
methyl groups, four of which were singlets and three were displayed as doublets at δH 0.88 (d, 
J = 1.3 Hz), δH 1.01 (d, J = 1.7 Hz) and δH 1.03 (d, J = 1.7 Hz). Moreover, an axial 
hydroxymethine at δH 3.28 (m), and two exomethylene protons displayed as broad singlets at 
δH 4.66 and δH 4.71 could also be observed. 
The 13C-NMR spectrum displayed thirty-one carbon signals that were discriminated by 
a DEPT experiment as seven methyls, eleven methylenes (one sp2 at δC 106.1), six methines 
(one oxygen-bearing carbon at δC 79.0) and five quaternary carbons (one olefinic at δC 157.1). 
All data described above was in agreement with those reported in the literature allowing 
the identification of compound 9 as 24-methylenecycloartanol [97]. 
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  Table 16 1H NMR data for compound 9 
(CDCl3, 1H 300 MHz, δ in ppm, J in Hz) 
Position 1H (J in Hz) 
3 3.28 dd (11.0; 4.4) 
18 0.96 s 
19α 0.55 d (4.23) 
19β 0.33 d (4.21) 
21 0.88 d (1.7) 
23 5.29 s 
26 1.30 s 
27 1.03 d (1.7) 
28 0.89 s 
29 1.01 d (1.7) 
30 0.80 s 
31α 4.66 d (1.5) 
31β 4.71 d (1.8) 
 
Table 17 13C NMR data for compound 9 
(CDCl3, 13C 75.45 MHz, δ in ppm) 
Position 13C DEPT 
1 32.1 CH2 
2 30.5 CH2 
3 79.0 CH 
4 40.6 C 
5 47.2 CH 
6 21.3 CH2 
7 28.3 CH2 
8 48.1 CH 
9 20.1 C 
10 26.2 C 
11 26.2 CH2 
12 35.7 CH2 
13 45.4 C 
14 48.9 C 
15 32.9 CH2 
16 26.6 CH2 
17 52.4 CH 
18 18.2 CH3 
19 29.9 CH2 
20 36.3 CH3 
21 18.4 CH 
22 31.5 CH2 
23 29.5 CH2 
24 157.1 C 
25 33.9 CH 
26 22.0 CH3 
27 22.1 CH3 
28 19.5 CH3 
29 25.6 CH3 
30 14.2 CH3 
31 106.1 CH2 
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Compound 10 was obtained as a white amorphous powder. 
The 1H-NMR spectrum showed signals for two tertiary methyl groups at δH 1.22 (s) and 
δH 1.46 (s), two secondary methyl groups at δH 1.24 (d, J = 6.8 Hz) and 1.38 (m), and three 
protons geminal to the ester functions at δH 4.86 (s), 5.61 (d, J = 18.1, 9.8 Hz), and 5.67 (d, J 
= 9.1 Hz). Two double bonds were also observed, one endocyclic at δH 5.90 (m) and δH 5.93 
(s) and an exocyclic one at δH 5.12 (br s) and 4.86 (br s). A proton signal at δH 3.47 without 
correlation in the HMQC spectrum suggested the existence of a hydroxyl group in the 
molecule.  
Besides the signals due to the ester functions, the 13C-NMR spectrum (Table 18) 
exhibited thirty-carbon resonances, that were discriminated by a DEPT experiment as four 
methyl groups (δC 17.8, 24.6 and 20.0), three methylenes (one sp2 at δC 116.9), seven methines 
(two sp2 at δC 136.9 and 132.8 and three oxymethines at δC 77.9, 73.3 and 72.4), six quaternary 
carbons (two carbonyl groups at δC 208.2 and 204.6, one oxygenated carbon at δC 82.9 and an 
olefinic carbon at δC 140.2). The combined analysis of 2D-NMR spectra allowed the 
unambiguous assignment of all 1H and 13C resonances (Figure 15). 
The compound was identified as euphopubescenol and all of the spectroscopic data was  
in agreement with the literature [98]. 
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Table 18 NMR data of compound 10 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
1α 2.41 dd (10.4; 1.6) 
38.9 CH2 16 
1β 2.41 dd (10.4; 1.6) 
2 2.91 m 36.9 CH 1α, 1β, 16, 
3 5.61 d (10.5) 77.9 CH 1α, 1β, 16 
4 - - 82.9 C - 
5 4.86 s 73.3 CH 17α, 17β 
6 - - 140.2 C 7α, 7β,8, 17α, 17β 
7α 1.71 dd (14.9; 9.2) 
36.0 CH2 5, 8, 17α, 17β, 
7β 2.00 s 
8 5.67 d (9.1) 72.4 CH 7α 
9 - - 208.2 C 18, 19 
10 - - 50.7 C 11, 12, 18, 19 
11 5.91 m 136.9 CH 13, 18, 19 
12 5.84 s 132.8 CH 20 
13 3.84 m 46.9 CH 11, 12, 20 
14 - - 204.6 C 1α, 1β, 20 
15 - - 94.6 C 1α, 1β, 5 
16 1.24 d (6.8) 17.8 CH3 
1α, 1β, 3, 12, 18, 
19 
17α 4.85 s 
116.9 CH2 5, 7α, 7β 
17β 5.12 br s 
18 1.22 s 24.6 CH3 11, 19 
19 1.46 s 24.6 CH3 11, 18 
20 1.38 d (6.5) 20.2 CH3 - 
3-OBz 
- - 166.6 C 3, 2’, 6’ 
- - 129.1 C - 
7.97 m 130.2 CH - 
7.43 m 128.5 CH - 
7.57 m 133.7 CH - 
5-OAc 
- - 168.4 C 5 
2.08 s 20.7 CH3 - 
8-OAc 
- - 169.9 C - 
1.91 s 20.4 CH3 - 
15-OAc 
- - 168.9 C - 
2.16 s 21.1 CH3 - 
 




Figure 15 1H-spin systems of compound 10 assigned by HMQC and 1H-1H COSY (-) and their connection by 
the main 2JC-H and 3JC-H correlations displayed in the HMBC spectrum (). 
 




 Compound 11 was isolated as white crystals (m.p. 205 oC). This compound was 
identified as helioscopinolide A on the basis of the comparison of its spectroscopic data to 
those found in the literature [99]. 
The 1H-NMR spectrum showed signals for three tertiary methyl groups displayed as 
singlets at δH 0.81, 0.92 and 1.02 and one vinylic methyl at δH 1.82 (d, J = 1.6 Hz). Moreover, 
this spectrum also showed signals for an olefinic proton at δH 6.27 (s) and two protons on 
oxygen-bearing carbons at δH 3.27 (dd, J = 11.6 and 4.4 Hz) and 4.85 (ddd, J = 13.5, 6.2 and 
1.8 Hz). 
The 13C-NMR spectrum revealed the presence of twenty signals, discriminated by a 
DEPT experiment as four methyl groups (one vinylic at δC 8.4), five methylenes, five methines 
(two of which oxygenated at δC 76.0 and 78.7 and one olefinic at δC 114.3), and six quaternary 
carbons (one carbonyl at δC 175.4, and three olefinic at δC 116.6, 151.6 and 156.2). 
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All the spectroscopic data was compared to those described in the literature [99] and 
confirmed that this compound was an ent-abietane diterpenic lactone, identified as 
helioscopinolide A. 
 
Table 19 NMR data of compound 11 (CDCl3, 1H 300 MHz, 13C 75.45 MHz, δ in ppm, J in Hz). 
Position 1H (J in Hz) 13C DEPT HMBC 
1 1.95 dt (13.1; 3.6) 37.5 CH2 19, 3, 10, 5 
2 1.62 m 27.7 CH2 20 
3 3.27 dd (11.6; 4.4) 78.7 CH 18, 17, 4 
4 - - 39.2 C 18 
5 1.14 dd (12.5; 2.5) 54.5 CH 19, 6, 17, 9, 3 
6 1.87 dt (5.2; 2.5) 23.6 CH2 16, 13, 8, 15, 
7 2.49 m 37.1 CH2 14, 9, 5, 8 
8 - - 151.6 C - 
9 2.16 d (8.9) 51.7 CH 
19, 2, 1, 10, 5, 12, 14, 8, 
13, 
10 - - 41.3 C - 
11 2.53 m 27.7 CH2 6, 10, 9, 12, 14, 8, 13, 5 
12 4.85 ddd (13.5; 6.2; 1.8) 76.0 CH 11, 13 
13 - - 156.2 C - 
14 6.27 s 114.3 CH 7, 9, 12, 15, 13 
15 - - 116.6 C - 
16 - - 175.4 C - 
17 1.02 s 28.8 CH3 18, 4, 5, 3 
18 0.81 s 15.7 CH3 2, 3, 4, 5 
19 0.92 s 16.8 CH3 12, 5, 9, 10, 1 
20 1.82 d (1.6) 8.4 CH3 16, 13, 15, 12 
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2. MOLECULAR DERIVATIZATION of methyl gallate 
 
Considering the several biological activities of gallic acid derivatives described in the 
literature [100-103], and that methyl gallate (8) was isolated from E. boetica in large amount, 
some chemical transformations were carried out taking advantage of its simple structure and 
chemical reactivity (Figure 16). 
Three main reactions were considered: i) methylation of the hydroxyl groups on the 
aromatic ring by reaction with dimethylsulfate, obtaining methyl 3,4,5-trimethoxybenzoate 
(8.1); ii) reaction of methyl 3,4,5-trimethoxybenzoate with hydrazine yielding 3,4,5-
trimethoxybenzohydrazide (8.2); iii) condensation of the 3,4,5-trimethoxybenzohydrazide 
(8.2) with aromatic aldehydes to yield imines 8.3-8.5. The chemical structures of all the 
compounds were deduced from their NMR data.  
 
 









Scheme 3 General representation of methyl gallate (8) derivatives (8.1-8.5). 
 
2.1. Methylation of methyl gallate and formation of the carbohydrazide  
 
The first chemical transformation carried out was the methylation of the hydroxyl 
groups linked to the benzene ring of methyl gallate (8). Methyl gallate (8) was suspended in 
acetone and combined with an excess of dimethylsulphate and K2CO3 yielding methyl 3,4,5-
trimethoxybenzoate (8.1). After purification, 8.1 was suspended in ethanol, treated with 
NH2NH2.H2O 64% and refluxed for 24h. The solid obtained was filtered and recrystallized 
from hot methanol yielding 3,4,5-trimethoxybenzohydrazide (8.2) (78.5%) [103] (Scheme 4). 




Scheme 4 Transformation of 8 into 8.1 using dimethylsulfate and, subsequently, into 8.2 with hydrazine 
hydrate. 
 
3,4,5-trimethoxybenzohydrazide (8.2) then underwent a condensation reaction with the 
aromatic aldehydes (Table 20) to yield the corresponding imines (8.3-8-5) (Scheme 5). 
 
 
Scheme 5 General reaction mechanism of 3,4,5-trimethoxybenzohydrazide (8.2) with aromatic aldehydes to 
yield compounds 8.3-8.5. 
 








The structural elucidation of the derivatives 8.2-8.5 was achieved by comparison of 
their spectroscopic data with those of methyl gallate (8). It should be noted, however, that, due 
to poor spectral resolution of some of the derivatives when dissolved in CDCl3, other solvents 
had to be used to overcome this problem, such as MeOD4 and DMSO-d6. 
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With the exception of the signals due to the three new methyl groups on positions 3, 4 
and 5 and the new imine moiety (8.1-8.5), the analysis of 1H-NMR and 13C-NMR showed very 
similar data to that of methyl gallate (Tables 21 and 22). 





















2 7.03, s 7.30, s 7.15, s 7.22, s 7.25, s 7.23, s 
6 7.03, s 7.30, s 7.15, s 7.22, s 7.25, s 7.23, s 
3-OCH3 - 3.90, s 3.89, s 3.86, s 3.86, s 3.75, s 
4-OCH3 - 3.90, s 3.81, s 3.77, br s 3.77, s 3.78, s 
5-OCH3 - 3.90, s 3.89, s 3.86, s 3.86, s 3.75, s 
7-OCH3 3.8, s 3.92, s - - - - 
2’ - - - 7.72, d (8.3) 8.01, d (8.8) 7.38, d (8.5) 
3’ - - - 6.92, d (8.3) 8.23, d (8.8) 6.42, d (8.47) 
4’-OCH3 - - - 3.77, br s - - 
5’ - - - 6.92, d (8.3) 8.23, d (8.8) 6.42, d (8.47) 
6’ - - - 7.72, d (8.3) 8.01, d (8.8) 7.38, d (8.5) 
7’ - - - 8.25, s 8.40, s 8.28 
N-(CH3)2 - - - - - 2.83, s 
CH=N - - - - - 8.28, s 
 
  




















1 126.3 129.5 129.5 130.6 129.5 129.3 
2  106.8 105.8 105.8 106.3 106.5 104.9 
3  153.0 154.5 154.5 154.5 154.6 151.9 
4 142.2 142.1 142.1 141.8 141.6 140.9 
5 106.8 105.8 105.8 154.5 154.6 104.9 
6 153.0 154.5 154.5 106.3 106.5 151.9 
7 166.9 169.1 169.1 163.2 164.1 164.1 
3-OCH3 56.4 56.7 56.7 56.8 56.9 56.3 
4-OCH3 61.1 61.1 61.1 61.2 61.3 61.0 
5-OCH3 56.4 56.7 56.7 56.8 56.9 56.3 
7-OCH3 52.4 - - - - - 
1’ - - - 126.6 122.7 121.3 
2’  - - - 128.0 125.0 128.9 
3’  - - - 114.1 125.0 111.7 
4’ - - - 163.1 149.8 153.2 
5’ - - - 114.1 125.0 111.7 
6’ - - - 128.0 125.0 128.9 
7’ - - - 150.8 149.8 150.1 
4’-OCH3 - - - 55.9 - - 
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1. GENERAL EXPERIMENTAL PROCEDURES 
 
Analytical thin layer chromatography (TLC) was performed on precoated silica-gel F254 
plates (Merck 5554) and visualized under UV light (254 and 366 nm) and by spraying with 
H2SO4/MeOH (1:1) followed by heating. Preparative TLC chromatography was carried out on 
20 x 20 cm silica plates (Merck 5774). Column chromatography (CC) was performed over SiO2 
(Merck 9385) or using CombiFlash® Rf 200 (Teledyne Isco) with SiO2 or reverse-phase C18 
prepacked columns. Column chromatography on reverse-phase C18 silica (YMC-GEL ODS-A 
12nm S-50µm AA12S50) was also performed.  
High-performance liquid chromatography (HPLC) was performed on a Merck-Hitachi 
instrument, with UV detection and a Merck-Hitachi integrator. Analytical studies and semi 
preparative HPLC were performed with Merck LiChrospher columns: 100 RP-18 (5 μm, 125 
x 4 mm) and 100 RP-18 (10 μm, 250 x 10 mm), respectively. The HPLC study was carried out 
with several different mixtures of MeOH/H2O as mobile phase. 
Infrared (IR) spectra were collected on an Affinity-1 (Shimadzu) FTIR 
spectrophotometer in KBr pellets and only the most significant absorption bands are reported.  
NMR spectra were recorded on a Bruker Fourier 300 spectrometer (1H 300 MHz; 13C 
75 MHz) using CDCl3, CD3OD, DMSO-d6 or CD3COCD3 as solvents. 1H and 13C chemical 
shifts are expressed in δ (ppm) and the proton coupling constants (J) in hertz (Hz).  
Low resolution mass spectrometry (ESI-MS) was performed on a triple quadrupole 
(QT) mass spectrometer (Micromass Quattro Micro API, Waters) with ionization by 
electrospray (ESI), operating in positive mode.
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2. PHYTOCHEMICAL STUDY OF Euphorbia boetica 
2.1. Extraction and isolation 
 
Euphorbia boetica Boiss. (Euphorbiaceae) was collected at Alcochete, Portugal (2014), 
and identified by Dr. Teresa Vasconcelos of Instituto Superior de Agronomia (ISA), University 
of Lisbon. A voucher has been deposited at the herbarium of ISA. 
The air-dried powdered plant (17.2 kg) was extracted exhaustively with methanol at 
room temperature. Evaporation of the solvent (under vacuum, 40 °C) from the crude extract 
yielded a residue of 4.1 kg. This residue was resuspended in MeOH/H2O solution (1:2) and 
extracted with EtOAc. The ethyl acetate-soluble fraction was dried (Na2SO4) and evaporated 
under vacuum, yielding a residue (2.2 kg), which was chromatographed over SiO2, using 
mixtures of n-hexane/EtOAc (1:0 to 0:1) and EtOAc/MeOH (9:1 to 3:7), in increasing gradients 
of 5%. According to differences in composition as indicated by TLC, seven crude fractions 
were obtained (fractions A−G) (Table 23). The process of extraction and fractionation were 
both conducted by other members of our Natural Products group. 
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2.1.1. Study of Fraction B 
Fraction B (8.965 g, eluted with n-hexane/EtOAc 3:1), was chromatographed over SiO2 
(200 g) and eluted with mixtures of n-hexane/EtOAc with increasing polarity. According to 
differences in composition as indicated by TLC, ten fractions were obtained (Scheme 6). 
Scheme 6 Overall workup of Fraction B. 
 
2.1.1.1. Study of fractions 28-34 and 35-36 
Fractions 28-34 (1.05 g) and 35-36 (0.42 g) were precipitated with n-hexane/EtOAc, 
yielding 0.8845 g of compound 9 as white crystals. 
 
24-Methylenecycloartanol (9)  
 
 
1H NMR (300 MHz, CDCl3): δ 0.33 (1H, d, J = 4.21 Hz, H-19β), 0.55 (1H, d, J = 4.23 
Hz, H-19α), 0.80 (3H, s, CH3-30), 0.88 (1H, d, J = 1.7 Hz, H-21), 0.89 (3H, s, CH3-28), 0.96 
(3H, s, CH3-18), 1.01 (3H, d, J = 1.7 Hz, CH3-29), 1.03 (3H, d, J = 1.7 Hz, CH3-27), 1.3 (3H, 
s, CH3-26), 3.28 (1H, dd, J = 11.0 and 4.4 Hz, H-3), 4.66 (1H, d, J = 1.5 Hz, H-31α), 4.71 (1H, 
d, J = 1.8 Hz, H-31β), 5.29 (2H, s, CH2-23). 
 
White crystals 
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13C NMR (75.45 MHz, CDCl3): δ 32.1 (C-1), 30.5 (C-2), 79.0 (C-3), 40.6 (C-4), 47.2 
(C-5), 21.3 (C-6), 28.3 (C-7), 48.1 (C-8), 20.1 (C-9), 26.2 (C-10), 26.2 (C-11), 35.7 (C-12), 
45.4 (C-13), 48.9 (C-14), 32.9 (C-15), 26.6 (C-16), 52.4 (C-17), 18.2 (C-18), 29.9 (C-19), 36.3 
(C-20), 18.4 (C-21), 31.5 (C-22), 29.5 (C-23), 157.1 (C-24), 33.9 (C-25), 22.0 (C-26), 22.1 (C-
27), 19.5 (C-28), 25.6 (C-29), 14.2 (C-30), 106.1 (C-31). 
 
2.1.2.  Study of Fraction D 
Fraction D (62.88 g, eluted with n-hexane/EtOAc 13:7 to 6:4) was subjected to 
chromatographic fractionation (SiO2, 1 Kg) using mixtures of n-hexane/EtOAc (1:0 to 0:1) to 
yield fractions D1 to D9 (Scheme 7). 
 
Scheme 7 Overall workup of fraction D and studied subfractions. 
 
2.1.2.1. Study of fraction D4 
Fraction D4 (10.42 g) was chromatographed using a reverse-phase C18 column (400 g; 














Scheme 8 General workup of Fraction D4 and isolated compounds. 
 
Fraction D4.1 (eluted with MeOH/H2O (7:3)) was evaporated and recrystallized, from 
n-hexane/EtOAc, to afford 0.284 g of compound 6 (Epoxyboetirane A). 
 
Epoxyboetirane A (6)  
 
. 
1H NMR (300 MHz, CDCl3): δ 0.85 (3H, d, J = 6.4 Hz, CH3-16), 0.90 (1H, m, H-7α), 
1.07 (1H, m, H-9), 1.18 (3H, s, CH3-18), 1.18 (3H, s, CH3-19), 1.46 (1H, m, H-11), 1.48 (1H, 
m, H-1β), 1.70 (2H, m, H-8), 1.83 (3H, s, CH3-20), 1.86 (1H, dd, J = 9.2 and 3.6 Hz, H-4), 2.00 
(3H, s, 3-OCOCH3), 2.06 (3H, s, 5-OCOCH3), 2.08 (3H, s, 15-OCOCH3), 2.1 (1H, m, H-2), 
2.11 (1H, m, H-7β), 2.29 (1H, br s, H-17α), 2.46 (1H, d, J = 3.4 Hz, H-17β), 3.38 (1H, dd, J = 
14.4 and 8.4 Hz, H-1α), 5.44 (1H, t, J = 3.4 Hz, H-3), 6.19 (1H, t, J = 9.3 Hz, H-5), 6.57 (1H, 














White amorphous powder 
IR, max cm-1 (KBr): 1736, 1671, 1256 
(lit. 1734, 1671) [13] 
ESI-MS, m/z: 477 [M + H]+ 




13C NMR (75.45 MHz, CDCl3): δ 48.0 (C-1), 37.6 (C-2), 80.4 (C-3), 50.1 (C-4), 65.3 
(C-5), 59.0 (C-6), 33.6 (C-7), 20.1 (C-8), 34.3 (C-9), 25.7 (C-10), 29.1 (C-11), 143.9 (C-12), 
136.1 (C-13), 197.0 (C-14), 91.9 (C-15), 14.1 (C-16), 55.4 (C-17), 29.0 (C-18), 16.8 (C-19), 
12.5 (C-20), 170.4 (3-OCOCH3), 20.9 (3-OCOCH3), 170.7 (5-OCOCH3), 21.1 (OCOCH3), 
165.9 (15-OCOCH3), 22.0 (OCOCH3). 
 
Fraction D4.2, eluted with MeOH/H2O (9:1), was evaporated, and the residue (1.2 g) 
was separated on a Combiflash system (120 g, RediSepRf) with n-hexane/EtOAc (1:0 to 0:1, 
5% gradients; 7 ml/min). To obtain compound 3, a sub fraction was recrystallized with n-
hexane yielding 0.131 g of pure compound. 
 
Phorboboetirane A (3) 
 
1H NMR (300 MHz, CDCl3): δ 0.76 (1H, d, J = 4.8 Hz, H-14), 0.96 (3H, d, J = 6.9 
Hz, CH3-4’), 0.98 (3H, d, J = 6.9 Hz, CH3-4’), 1.09 (3H, d, J = 6.3 Hz, CH3-18), 1.14 (3H, d, 
J = 4.5 Hz, CH3-5’), 1.15 (3H, d, J = 4.5 Hz, CH3-3’’), 1.17 (3H, d, J = 6.8 Hz, CH3-3’’), 1.18 
(3H, s, CH3-17), 1.20 (3H, s, CH3-16), 1.7 (1H, m, H-11), 1.80 (3H, s, CH3-19), 1.89 (3H, t, J 
= 1.5 Hz, CH3-20), 1.89 (1H, m, H-3’), 1.99 (1H, m, H-8), 2.22 (1H, m, H-2’), 2.55 (1H, m, 
H-2’’), 3.12 (1H, dd, J = 6.6 and 4.5 Hz, H-4), 3.62 (1H, m, H-10), 4.44 (1H, d, J = 4.5 Hz, H-
5), 4.85 (1H, br s, H-7), 5.47 (1H, m, H-12), 7.04 (1H, s, H-1). 
 
13C NMR (75.45 MHz, CDCl3): δ 154.8 (C-1), 144.1 (C-2), 207.7 (C-3), 56.2 (C-4), 
71.0 (C-5), 137.7 (C-6), 125.6 (C-7), 40.2 (C-8), 78.5 (C-9), 47.9 (C-10), 43.1 (C-11), 74.1 (C-
12), 64.9 (C-13), 38.1 (C-14), 25.5 (C-15), 16.6 (C-16), 24.9 (C-17), 11.8 (C-18), 10.6 (C-19), 
White crystals 
IR, maxcm-1 (KBr): 3303, 1757, 1699 
ESI-MS, m/z: 517 [M + H]+ 
m.p.: 190 oC 
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27.3 (C-20), 175.8 (C-1’), 47.4 (C-2’), 31.3 (C-3’), 20.9 (C-4’), 19.5 (C-4’), 18.6 (C-5’), 179.4 
(C-1’’), 34.4 (C-2’’), 18.6 (C-3’’), 14.7 (C-3’’). 
 
2.1.2.2. Study of fraction D5 
Fraction D5 (10.42 g) was chromatographed through a reverse-phase C18 column (400 
g; MeOH/H2O, 1:1-1:0) using increasing gradients of 10%) (Scheme 9). 
 
 
Scheme 9 General workup of Fraction D5 and isolated compounds. 
 
Fraction D5.1 (0.689 g, eluted with MeOH/H2O (7:3), was chromatographed over SiO2 
(40 g with n-hexane/CH2Cl2 (1:9 and 0:1) and CH2Cl2/acetone (1:0 to 9:1), used in increasing 
gradients of 1%. Some fractions were associated per their similarity as indicated by TLC (0.190 
g) and further purified through chromatography over SiO2 (30 g) with CH2Cl2/acetone (1:0 to 
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Premyrsinol-3-propanoate-5-benzoate-7,13,17-triacetate (2)  
 
 
 1H NMR (300 MHz, CDCl3): δ 0.71 (1H, d, J = 3.2 Hz, H-11), 0.73 (1H, br s, H-9), 
0.84 (3H, d, J = 6.3 Hz, CH3-16), 0.93 (3H, s, CH3-18), 0.94 (3H, t, J = 7.5 Hz, OCOCH2CH3), 
1.04 (3H, s, CH3-19), 1.45 (3H, s, 7-OCOCH3), 1.63 (1H, m, H-1β), 1.70 (3H, s, CH3-20), 1.85 
(1H, m, H-2), 1.86 (1H, m, H-8β), 2.1 (3H, s, 13-OCOCH3), 2.14 (1H, m, H-8α), 2.14 (3H, s, 
17-OCOCH3), 2.26 (2H, q, J = 7.5 Hz, 3-OCOCH2CH3), 2.39 (1H, dd, J = 9.8 and 3.9 Hz, H-
4), 3.14 (1H, dd, J = 13.5 and 7.5 Hz, H-1α), 3.5 (1H, d, J = 6.6 Hz, H-12), 4.29 (1H, d, J = 
11.4 Hz, H-17β), 4.68 (1H, d, J = 11.4 Hz, H-17α), 4.78 (1H, d, J = 6.6 Hz, H-7), 5.36 (1H, t, 
J = 3.3 Hz, H-3), 6.36 (1H, d, J = 11.4 Hz, H-5), 7.35 (2H, t, J = 7.65 Hz, H-3’ and H-5’), 7.49 
(1H, t, J = 7.35 Hz, H-4’) 7.86 (2H, d, J = 7.8 Hz, H-2’ and H-6’). 
 
13C NMR (75.45 MHz, CDCl3): δ 42.9 (C-1), 37.3 (C-2), 78.2 (C-3), 50.3 (C-4), 69.9 
(C-5), 47.8 (C-6), 70.7 (C-7), 22.1 (C-8), 18.9 (C-9), 18.4 (C-10), 23.9 (C-11), 35.1 (C-12), 
85.8 (C-13), 204.4 (C-14), 84.2 (C-15), 13.9 (C-16), 62.9 (C-17), 14.9 (C-18), 29.5 (C-19), 
25.0 (C-20), 173.6 (3-OCOCH2CH3), 27.6 (3-OCOCH2CH3), 8.8 (3-OCOCH2CH3), 165.2 (5-
OCOBz), 129.9 (C-1’), 129.7 (C-2’ and 6’), 128.3 (C-3’ and 5’), 133.1 (C-4’), 170.8 (7-
OCOCH3), 20.6 (7-OCOCH3), 170.8 (13-OCOCH3), 21.5 (13-OCOCH3), 170.3 (17-
OCOCH3), 21.4 (17-OCOCH3). 
 




IR, maxcm-1 (KBr): 3487, 1739, 1700 
(lit. 3450, 1745, 1660, 1370, 1297, 1241, 
1136, 1031 cm-1) [86] 
ESI-MS, m/z: 671 [M + H]+ (lit. 670.2989 
[M]+) [86] 
m.p.: 190 oC (lit. N/A)  
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Epoxyboetirane K (7) [13] 
 
 
1H NMR (300 MHz, CDCl3): δ 0.83 (3H, d, J = 6.8 Hz, CH3-16), 0.89 (1H, t, J = 12.8 
Hz, H-7α), 1.06 (1H, m, H-9), 1.1 (3H, t, J = 7.6 Hz, 3-OCOCH2CH3), 1.18 (3H, s, CH3-18), 
1.18 (3H, s, CH3-19), 1.46 (1H, m, H-11), 1.50 (1H, dd, J = 9.2 and 3.6 Hz, H-1α), 1.69 (1H, 
t, J = 6.8 Hz, H-8α), 1.82 (3H, s, CH3-20), 1.87 (1H, dd, J = 11.0 and 3.2 Hz, H-4), 2.02 (1H, 
m, H-8β), 2.04 (3H, s, 5-OCOCH3), 2.07 (3H, s, 15-OCOCH3), 2.11 (1H, m, H-2), 2.11 (1H, 
m, H-7β), 2.29 (1H, m, H-17α), 2.29 (2H, d, J = 2.7 Hz, 3-OCOCH2CH3), 2.46 (1H, d, J = 3.6 
Hz, H-17β), 3.39 (1H, dd, J = 11.4 and 8.4 Hz, H-1β), 5.48 (1H, t, J = 3.2 Hz, H-3), 6.17 (1H, 
d, J = 9.2 Hz, H-5), 6.56 (1H, d, J = 11.6 Hz,H-12). 
 
13C NMR (75.45 MHz, CDCl3): δ 48.1 (C-1), 37.7 (C-2), 80.2 (C-3), 50.1 (C-4), 65.3 
(C-5), 59.0 (C-6), 33.7 (C-7), 20.1 (C-8), 34.9 (C-9), 25.7 (C-10), 29.1 (C-11), 143.9 (C-12), 
136.1 (C-13), 197.0 (C-14), 91.9 (C-15), 14.1 (C-16), 55.6 (C-17), 29.0 (C-18), 16.8 (C-19), 
12.5 (C-20), 173.6 (3-OCOCH2CH3), 27.8 (3-OCOCH2CH3), 9.1 (3-OCOCH2CH3), 170.7 (5-
OCOCH3), 21.1 (5-OCOCH3), 169.8 (15-OCOCH3), 21.9 (15-OCOCH3). 
 
2.1.2.3. Study of fraction D6 
Fraction D6 (10.42 g) was chromatographed using reverse-phase C18 column (800 g; 
MeOH/H2O 7:3 to 9:1, 10% gradient). Fractions D6.1-D6.3 were eluted using MeOH/H2O (7:3) 
(Scheme 10). 
White crystals 
IR, maxcm-1 (KBr): 1738, 1652 
m.p.: 205 oC (lit. 216-217 oC)  




Scheme 10 General workup of Fraction D6 and isolated compounds. 
 
 Fraction D6.2 (1 g) was chromatographed over SiO2 (70 g, CH2Cl2/acetone 1:0 to 97:3, 
1% gradient; CH2Cl2/acetone 19:1, 100 mL; CH2Cl2/acetone 9:1, 100 mL; EtOAc 100 mL), 
yielding 0.0683 g of compound 1. 
 
Euphomyrsinane A (1) 
 
 
1H NMR (300 MHz, CDCl3): δ 0.72 (1H, d, J = 3.3 Hz, H-11), 0.74 (1H, d, J = 1.8 
Hz, H-9), 0.87 (3H, d, J = 6.6 Hz, CH3-16), 0.94 (3H, s, CH3-18), 1.05 (3H, s, CH3-19), 1.46 
(3H, s, 13-OCOCH3), 1.65 (1H, s, H-1β), 1.71 (3H, s, CH3-20), 1.8 (1H, m, H-8β), 1.84 (1H, 
m, H-2), 1.95 (3H, s, 7-OCOCH3), 2.12 (3H, s, 3-OCOCH3), 2.13 (1H, m, H-8α), 2.16 (3H, s, 
17-OCOCH3), 2.39 (1H, dd, J = 11.6 and 3.9 Hz, H-4), 3.14 (1H, dd, J = 13.5 and 7.5 Hz, H-















IR, maxcm-1 (KBr): 3487, 1739, 1700  
ESI-MS, m/z: 657 [M + H]+ 
m.p.: 235 oC 
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H-17α), 4.8 (1H, d, J = 6.3 Hz, H-7), 5.35 (1H, t, J = 3.45 Hz, H-3), 6.38 (1H, d, J = 11.4 Hz, 
H-5), 7.38 (2H, t, J = 7.65 Hz, H-3’ and H-5’), 7.51 (1H, t, J = 7.35 Hz, H-4’), 7.88 (2H, d, J 
= 7.8 Hz, H-2’ and H-6’). 
 
13C NMR (75.45 MHz, CDCl3): δ 42.9 (C-1), 37.3 (C-2), 78.6 (C-3), 50.3 (C-4), 69.9 
(C-5), 47.9 (C-6), 70.7 (C-7), 22.2 (C-8), 19.0 (C-9), 18.4 (C-10), 24.0 (C-11), 35.1 (C-12), 
85.8 (C-13), 204.4 (C-14), 84.2 (C-15), 14.0 (C-16), 62.9 (C-17), 15.0 (C-18), 29.6 (C-19), 
25.1 (C-20), 170.9 (3-OCOCH3), 21.4 (3-OCOCH3), 165.3 (5-OCOBz), 129.7 (C-1’), 129.9 
(C-2’ and C-6’), 128.4 (C-3’ and C-5’), 133.2 (C-4’), 170.6 (7-OCOCH3), 21.1 (C-7-
OCOCH3), 170.9 (13-OCOCH3), 20.6 (13-OCOCH3), 170.4 (17-OCOCH3), 21.5 (17-
OCOCH3). 
 
 Fraction D6.3 (1.4 g) was chromatographed using a reverse-phase C18 column (100 g; 
CH2Cl2/acetone 1:0 to 24:1, 2% gradient; CH2Cl2/acetone 19:1, 200 mL; CH2Cl2/acetone 37:3, 
600 mL; CH2Cl2/acetone 9:1, 200 mL), yielding several subfractions, associated according to 
their TLC profile. From these, subfraction D6.3.2 (0.0722 g) was purified by HPLC (MeOH/H2O 
62:38, 3 mL/min, 254 nm) yielding 0.0216 g of compound 5. 
 
Euphoboetirane A (5) 
 
 
1H NMR (300 MHz, CDCl3): δ 0.88 (3H, d, J = 5.1 Hz, CH3-16), 1.11 (1H, m, H-7α), 
1.12 (3H, s, CH3-18), 1.14 (1H, m, H-9), 1.14 (3H, s, CH3-19), 1.38 (1H, dd, J = 8.7 and 6.3 
Hz, H-11), 1.56 (1H, dd, J = 15.75 and 8.7 Hz, H-1α), 1.66 (3H, m, CH3-20), 1.69 (1H, d, J = 
5.1 Hz, H-8α), 1.96 (3H, s, 5-OCOCH3), 2.02 (3H, s, 3-OCOCH3), 2.07 (1H, s, H-8β), 2.09 
(3H, s, 15-OCOCH3), 2.20 (1H, m, H-7β), 2.24 (1H, m, H-2), 2.72 (1H, dd, J = 7.65 and 2.55 
Hz, H-4), 3.42 (1H, dd, J = 12.3 and 7.8 Hz, H-1β), 4.70 (1H, s, H-17α), 4.97 (1H, s, H-17β), 
White powder 
IR, maxcm-1 (KBr): 1736, 1644, 1613, 905 
(lit. 3439, 2924, 2856, 1740, 1627, 1453, 
1383, 1273, 1254, 1236, 1115, 1059, 1032, 
1018, 904, 713, 620, 450 cm-1) [93] 
ESI-MS, m/z: 461 [M + H]+ (lit. 483 [M + 
Na]+) [93] 
Phytochemical Studies: Experimental Section 
80 
 
5.53 (1H, t, J = 3.75 Hz, H-3), 6.04 (1H, d, J = 7.8 Hz, H-5), 6.49 (1H, dd, J = 11.4 and 1.2 
Hz, H-12). 
 
13C NMR (75.45 MHz, CDCl3): δ 48.4 (C-1), 37.3 (C-2), 80.3 (C-3), 52.3 (C-4), 65.9 
(C-5), 144.5 (C-6), 35.1 (C-7), 21.7 (C-8), 35.5 (C-9), 25.4 (C-10), 28.5 (C-11), 146.9 (C-12), 
134.3 (C-13), 197.0 (C-14), 92.4 (C-15), 14.2 (C-16), 115.7 (C-17), 16.9 (C-18), 29.1 (C-19), 
12.6 (C-20), 170.9 (3-OCOCH3), 21.4 (3-OCOCH3), 170.7 (5-OCOCH3), 21.0 (5-OCOCH3), 
170.0 (15-OCOCH3), 22.1 (15-OCOCH3). 
 
2.1.3. Study of fraction C6 
 
Fraction C6 (18.45 g) was eluted from the main column using n-hexane/EtOAc (7:3). 
This fraction was submitted to a reverse-phase chromatographic column (YMC-GEL ODS-A 
12nm S-50µm AA12S50) using MeOH/H2O 1:1 to MeOH/H2O (1:0) (Table 24). 
 
Table 24 Column chromatography of Fraction C6. 
Solvent Fractions 
Volume MeOH/H2O CH2Cl2  
1 L 1:1 - 1-2 
1 L 3:2 - 3-4 
2 L 7:3 - 5-9 
1 L 3:1 - 10-12 
1 L 4:1 - 13-14 
1 L 9:1 - 15-17 
2.25 L 1:0 - 18-20 
1 L - 1:0 Clean-up 
 
Compound 5 (2.5 g) was obtained from fractions 6-10. 
 
The mother liquors from fractions 8, 9 and fraction 11 were associated for further 
chromatographic studies. Fractions 12-14 were added for further chromatographic studies. 
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Phorboboetirane B (4) 
 
 
1H NMR (300 MHz, CDCl3): δ 1.0 (3H, d, J = 6.4 Hz, CH3-18), 1.1 (1H, d, J = 1.6 
Hz, H-14), 1.18 (3H, s, CH3-1’’’), 1.21 (3H, d, J = 3.4 Hz, 2’’’), 1.23 (3H, s, H-16), 1.33 (3H, 
s, H-17), 1.62 (3H, dd, J = 2.5 and 1.3 Hz, H-19), 1.7 (1H, d, J = 3.1 Hz, H-11), 1.75 (3H, s, 
H-20), 2.46 (1H, br s, H-8), 2.63 (1H, m, 13-OCOCH(CH3)2), 2.81 (1H, t, J = 4.4 Hz, H-4), 
3.81 (1H, m, H-10), 5.48 (1H, d, J = 4.9 Hz, H-7), 5.66 (1H, d, J = 9.6 Hz, H-12), 6.48 (1H, d, 
J = 3.7 Hz, H-5), 7.38 (2H, t, J = 7.6 Hz, H-3’ and H-5’), 7.48 (2H, m, H-3’’ and H-5’’), 7.52 
(1H, t, J = 2.0 Hz, H-4’), 7.58 (1H, m, H-4’’), 7.72 (1H, br s, H-1), 7.84 (2H, d, J = 1.5 Hz, H-
2’ and H-6’), 8.01 (1H, m, H-4’’). 
 
13C NMR (75.45 MHz, CDCl3): δ 161.0 (C-1), 138.0 (C-2), 205.5 (C-3), 49.3 (C-4), 
73.8 (C-5), 138.4 (C-6), 130.0 (C-7), 42.6 (C-8), 78.9 (C-9), 52.6 (C-10), 43.2 (C-11), 77.7 (C-
12), 65.2 (C-13), 36.8 (C-14), 26.5 (C-15), 23.8 (C-16), 17.2 (C-17), 15.5 (C-18), 10.2 (C-19), 
21.7 (C-20), 165.4 (5-OCOBz), 130.1 (C-1’ and C-1’’), 129.8 (C-2’ and C-6’), 128.4 (C-3’ and 
C-5’), 133.4 (C-4’), 166.1 (12-OCOBz), 129.8 (C-2’’ and C-6’’), 128.7 (C-3’’ and C-5’’), 
133.1 (C-4’’), 179.6 (13-OCOCH(CH3)2), 34.4 (13-OCOCH(CH3)2), 18.7 (C-1’’’), 18.8 (C-
2’’’). 
 
The mother liquors from fractions 15 and 16 were associated and submitted to further 
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2.1.3.1. Study of fraction 8-11 
This fraction (2.4 g) was submitted to chromatographic column (SiO2, 120 g) eluted with 
mixtures of n-hexane/CH2Cl2 of increasing polarity (Table 25).  
 








23-40 17:18 - 0.054 
41-47 9:10 1:0 0.0613 
48-97 - 1:0 0.9949 
98-155 - 50:1 0.46663 
156-158 - 50:1 0.0069 
159-161 - 50:1 0.0084 
162-163 - 97:3 0.0069 
164-174 - 97:3 0.3373 
175-207 - 97:3-3:1 0.0586 
208-end - 3:1 0.0702 
 
Compound 5 (0.467 g) was obtained from fraction 98-155. 
 
2.1.4. Study of Fraction E 
Fraction E (181 g, eluted with n-hexane/EtOAc 9:11-1:3) was fractioned by column 
chromatography (1.2 Kg, SiO2) and eluted with mixtures of n-hexane/EtOAc of increasing 
polarity Scheme 11). Compound 8 (methyl gallate) was obtained by recrystallization of fraction 
E (111-132) using EtOAc/n-hexane (Scheme 11). 
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 1H NMR (300 MHz, CDCl3): δ 3.8 (3H, s, 7-OCH3), 7.03 (2H, s, H-2 and H-6). 
 
 13C NMR (75.45 MHz, CDCl3): δ 120.0 (C-1), 108.6 (C-2 and C-6), 145.1 (C-3 and 





m.p.: 204 oC (lit. 201-203 oC) [105] 
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3. PHYTOCHEMICAL STUDY OF Euphorbia pubescens 
3.1. Extraction and isolation 
 
The air-dried powdered plant (7.5 kg) was extracted exhaustively with methanol at 
room temperature. Evaporation of the solvent (under vacuum, 40 °C) from the crude extract 
yielded a residue of 1.25 kg. This residue was resuspended in MeOH/H2O solution (1:2) and 
extracted with EtOAc. The ethyl acetate-soluble fraction was dried (Na2SO4) and evaporated 
under vacuum, yielding a residue (607 g), which was chromatographed over SiO2, using 
mixtures of n-hexane/EtOAc (1:0 to 0:1) and EtOAc/MeOH (9:1 to 3:7), in increasing gradients 
of 5%.  According to differences in composition as indicated by TLC, twelve crude fractions 
were obtained. Fraction 93-111 (19.15 g, eluted with n-hexane/EtOAc 7:3), was submitted to 
reverse-phase column chromatography (MeOH/H2O 1:1 to MeOH/H20 1:0). According to 
differences in composition as indicated by TLC, seven crude fractions were obtained (Scheme 
12). The process of extraction and fractionation were both conducted by other members of our 
Natural Products group. 
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3.1.1. Study of fraction 60:40-70:30 
 
This fraction (5.27 g) was submitted to column chromatography using n-hexane/EtOAc, 
starting at n-hexane/EtOAc 1:0 up to EtOAc/MeOH 4:1. Sub-fraction 61-72 (2.5195 g) was 
obtained using n-hexane/EtOAc 3:2 and submitted to a combiflash, yielding two fractions of 
interest: 27-29 (0.3291 g) and 30-35 (1.6647 g) that were submitted to chromatographic 
columns (Scheme 13). 
 
 
Scheme 13 Fraction 60:40 and 70:30 - workup. 
 
3.1.1.1. Study of fraction 27-29 
Fraction 27-29 (0.3291 g) was submitted to a chromatographic column using 100 g of 
SiO2 and eluted with mixtures of CH2Cl2/MeOH of increasing polarity to give, 11 mg of 
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 Euphopubescenol (10) 
 
 
 1H NMR (300 MHz, CDCl3): δ 1.22 (3H, s, CH3-18), 1.24 (3H, d, J = 6.8 Hz, CH3-
16), 1.38 (3H, d, J = 6.5 Hz, CH3-20), 1.46 (3H, s, CH3-19), 1.71 (1H, dd, J = 14.9 and 9.2 Hz, 
H-7α), 1.91 (3H, s, 8-OCOCH3), 2.00 (1H, s, H-7β), 2.08 (3H, s, 5-OCOCH3), 2.16 (3H, s, 15-
OCOCH3), 2.41 (2H, dd, J = 10.4 and 1.6 Hz, H-1α and H-1β), 2.91 (1H, m, H-2), 3.84 (1H, 
m, H-13), 4.85 (1H, s, H-17α), 4.86 (1H, s, H-5), 5.12 (1H, br s, H-17β), 5.61 (1H, d, J = 10.5 
Hz, H-3), 5.67 (1H, d, J = 9.1 Hz, H-8), 5.84 (1H, s, H-12), 5.91 (1H, m, H-11), 7.43 (2H, m, 
H-3’ and H-5’), 7.57 (1H, m, H-4’), 7.97 (2H, m, H-2’ and H-6’). 
 
 13C NMR (75.45 MHz, CDCl3): δ 38.9 (C-1), 36.9 (C-2), 77.9 (C-3), 82.9 (C-4), 73.3 
(C-5), 140.2 (C-6), 36.0 (C-7), 72.4 (C-8), 208.2 (C-9), 50.7 (C-10), 136.9 (C-11), 132.8 (C-
12), 46.9 (C-13), 204.6 (C-14), 94.6 (C-15), 17.8 (C-16), 116.9 (C-17), 24.6 (C-18 and C-19), 
20.2 (C-20), 166.6 (3-OCOBz), 129.1 (C-1’), 130.2 (C-2’ and C-6’), 128.5 (C-3’ and C-5’), 
133.7 (C-4’), 168.4 (5-OCOCH3), 20.7 (5-OCOCH3), 169.9 (8-OCOCH3), 20.4 (8-OCOCH3), 
168.9 (15-OCOCH3), 21.1 (15-OCOCH3). 
 
3.1.1.2. Study of fraction 30-35 
Fraction 30-35 (1.66 g) was submitted to a chromatographic column (SiO2, 70 g) and 
eluted with a mixture of CH2Cl2/acetone (1:0 to 4:1, 0.5% gradient) (Scheme 14). 
 
White amorphous powder 
 




Scheme 14 Overall workup of fraction 30-35. 
 
Sub-fraction 45 yielded 41mg of compound 10. 
Sub-fraction 40-91 yielded another 100 mg of pure compound 10. 
Sub-fraction 92-139 recrystalized from CH2Cl2/acetone to give 229 mg of compound 
11. 
 
Helioscopinolide A (11)  
 
  
 1H NMR (300 MHz, CDCl3): δ 0.81 (3H, s, CH3-18), 0.92 (3H, s, CH3-19), 1.02 (3H, 
s, CH3-17), 1.14 (1H, dd, J = 12.5 and 2.5 Hz, H-5), 1.62 (2H, m, H-2), 1.82 (3H, d, J = 1.6 
Hz, CH3-20), 1.87 (2H, dt, J = 5.2 and 2.5 Hz, H-6), 1.95 (2H, dt, J = 13.1 and 3.6 Hz, H-1), 
2.16 (1H, d, J = 8.9 Hz, H-9), 2.49 (2H, m, H-7), 2.53 (2H, m, H-11), 3.27 (1H, dd, J = 11.6 

























m.p.: 205 oC (lit. 208-209 ºC) [106] 




 13C NMR (75.45 MHz, CDCl3): δ 37.5 (C-1), 27.7 (C-2), 78.7 (C-3), 39.2 (C-4), 54.5 
(C-5), 23.6 (C-6), 37.1 (C-7), 151.6 (C-8), 51.7 (C-9), 41.3 (C-10), 27.7 (C-11), 76.0 (C-12), 
156.2 (C-13), 114.3 (C-14), 116.6 (C-15), 175.4 (C-16), 28.8 (C-17), 15.7 (C-18), 16.8 (C-19), 
8.4 (C-20).
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4. MOLECULAR DERIVATIZATION of Methyl 3,4,5-trihydroxybenzoate 
(methyl gallate) 
4.1. Methylation of methyl 3,4,5-trihydroxybenzoate  
 
 Methyl 3,4,5-trihydroxybenzoate (8, 2 g, 10.9 mmol) was suspended in acetone (30 
mL) with dimethylsulfate (DMSO4) (7 mL, 65 mmol) and K2CO3 (9 g, 65 mmol). The mixture 
was stirred and refluxed for 20 hours at 90 ̊ C until TLC analysis (CH2Cl2/MeOH, 19:1) showed 
complete disappearance of the starting material. The mixture was worked up by performing a 
flash chromatography column using a mixture of n-hexane/EtOAc to afford approximately 2.4 
g of methyl 3,4,5-trimethoxybenzoate (8.1). 
 
Methyl 3,4,5-trimethoxybenzoate (8.1) 
 
 
 1H NMR (300 MHz, CDCl3): δ 3.90 (9H, s, 3-OCH3, 4-OCH3 and 5-OCH3), 3.92 (3H, 
s, 7-OCH3), 7.30 (2H, s, H-2 and H-6). 
 
 13C NMR (75.45 MHz, CDCl3): δ 126.3 (C-1), 106.8 (C-2 and C-6), 153.0 (C-3 and 
C-5), 142.2 (C-4), 166.9 (C-7), 56.4 (3-OCH3 and 5-OCH3), 61.1 (4-OCH3), 52.4 (7-OCH3). 
 
4.2. Synthesis of 3,4,5-trimethoxybenzohydrazide  
 
 Methyl 3,4,5-trimethoxybenzoate (8.1, 2 g, 8.855 mmol) was suspended in ethanol (70 
mL) and treated with a solution of 20 mL of 64% hydrazine hydrate (34.8 mmol). The mixture 
was stirred and refluxed for 24 hours at 95 ˚C until TLC analysis showed complete 
consumption of the starting material. The residue obtained was recrystallized from hot 
methanol, yielding approximately 1.8 g of 3,4,5-trimethoxybenzohydrazide (8.2). 
 
White crystals 
η = 78.5 % 
m.p. = 84 oC 




 3,4,5-trimethoxybenzohydrazide (8.2) [107] 
 
 1H NMR (300 MHz, MeOD4): δ 3.81 (3H, s, 4-OCH3), 3.89 (6H, s, 3- and 5-OCH3), 
7.15 (2H, s, H-2 and H-6). 
 
 13C NMR (75.45 MHz, MeOD4): δ 129.5 (C-1), 105.8 (C-2 and C-6), 154.5 (C-3 and 
C-5), 142.1 (C-4), 169.1 (C-7), 56.7 (3- and 5-OCH3), 61.1 (4-OCH3).  
 
4.3. General procedure for the reaction of 3,4,5-trimethoxybenzohydrazide with 
aromatic aldehydes 
 
 3,4,5-trimethoxybenzohydrazide (8.2, 20 mg, 88 µmol) was suspended in methanol (15 
mL) and treated with suitable aromatic aldehyde (0.66 mmol). The reaction mixture was stirred 
and refluxed for 2 hours at 75 ˚C until TLC analysis showed complete disappearance of the 
starting material. The residue was evaporated under vacuum, resuspended in EtOAc and 
purified by preparative TLC eluted with CH2Cl2/MeOH 19:1 to give compounds 8.3-8.5. 
 
 3,4,5-trimethoxy-N'-(4-methoxybenzylidene)benzohydrazide (8.3) 
 
 Obtained from the reaction of compound 8.2 (20 mg, 88 µmol) with p-anisaldehyde 
(0.66 mmol). The reaction mixture was stirred for and refluxed for 2 hours at 75 oC. The residue 
was purified by preparative TLC eluted with CH2Cl2/MeOH (19:1) to afford 19.1 mg (135.03 
µmol, 61.74% yield of a white amorphous powder. 
White crystals 
η = 90% 
m.p.: 75 oC (lit. 77-78 oC)  





 1H NMR (300 MHz, CDCl3): δ 3.77 (6H, br s, 4-OCH3 and 4’-OCH3), 3.86 (6H, s, 3-
OCH3 and 5-OCH3), 6.92 (2H, d, J = 8.3 Hz, H-3’ and H-5’), 7.22 (2H, s, H-2 and H-6), 7.72 
(2H, d, J = 8.3 Hz, H-2’ and H-6’), 8.25 (1H, s, H-7’). 
 
 13C NMR (75.45 MHz, MeOD4): δ 130.6 (C-1), 106.3 (C-2 and C-6), 154.5 (C-3 and 
C-5), 141.8 (C-4), 163.2 (C-7), 56.8 (3- and 5-OCH3), 61.2 (4-OCH3), 126.6 (C-1’), 128.0 (C-
2’ and C-6’), 114.1 (C-3’ and C-5’), 163.1 (C-4’), 150.8 (C-7’), 55.9 (4’-OCH3). 
 
 3,4,5-trimethoxy-N'-(4-nitrobenzylidene)benzohydrazide (8.4) 
 
 Obtained from the reaction of compound 8.2 (20 mg, 88 µmol) with 4-
nitrobenzaldehyde (0.66 mmol). The reaction mixture was stirred for and refluxed for 2 hours 
at 75oC. The residue was purified by preparative TLC eluted with CH2Cl2/MeOH (19:1) to 




 1H NMR (300 MHz, CDCl3): δ 3.77 (3H, s, 4-OCH3), 3.86 (6H, s, 3- and 5-OCH3), 
7.25 (2H, s, H-2 and H-6), 8.01 (2H, d, J = 8.8 Hz, H-2’ and H-6’), 8.23 (2H, d, J = 8.8 Hz, 
H-3’ and H-5’), 8.40 (1H, s, H-7’). 
 
White amorphous solid 
η = 61.74% 
Amorphous powder 
η = 57.61% 
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 13C NMR (75.45 MHz, MeOD4): δ 129.5 (C-1), 106.5 (C-2 and C-6), 154.6 (C-3 and 
C-5), 141.6 (C-4), 164.1 (C-7), 56.9 (3- and 5-OCH3), 61.3 (4-OCH3), 122.7 (C-1’), 125.0 
(C-2’ and C-6’), 125.0 (C-3’ and C-6’), 149.8 (C-4’ and C-7’). 
 
 N'-(4-(dimethylamino)benzylidene)-3,4,5-trimethoxybenzohydrazide (8.5) 
 
 Obtained from the reaction of compound 8.2 (20 mg, 88 µmol) with 4-
(Dimethylamino)benzaldehyde (0.66 mmol). The reaction mixture was stirred for and refluxed 
for 2 hours at 75 oC. The residue was purified by preparative TLC eluted with CH2Cl2/MeOH 
(19:1) to afford 14.20 mg (39.73 µmol, 44.94% yield) of a yellow amorphous powder. 
 
 
 1H NMR (300 MHz, CDCl3): δ 2.83 (6H, s, N-(CH3)2), 3.75 (6H, s, 3- and 5-OCH3), 
3.78 (3H, s, 4-OCH3), 6.42 (2H, d, J = 8.47 Hz, H-3’ and H-5’), 7.23 (2H, s, H-2 and H-6), 
7.38 (2H, d, J = 8.5 Hz, H-2’ and H-6’), 8.28 (1H, s, H-7’). 
 
 13C NMR (75.45 MHz, CDCl3): δ 129.3 (C-1), 104.9 (C-2 and C-6), 151.9 (C-3 and 
C-5), 140.9 (C-4), 164.1 (C-7), 121.3 (C-1’), 128.9 (C-2’ and C-6’), 111.7 (C-3’ and C-6’), 
153.2 (C-4’), 150.1 (C-7’), 56.3 (3- and 5-OCH3), 61.0 (4-OCH3), 40.2 (4’-N(CH3)2. 
Yellow amorphous powder 
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 The main goal of this study was to search for bioactive compounds, mainly effective 
modulators of P-glycoprotein in resistant cancer cells using two main approaches: isolation and 
molecular derivatization of compounds found in high amounts. In a first stage, the 
phytochemical study of some fractions of Euphorbia boetica and Euphorbia pubescens 
(Euphorbiaceae) methanol extracts were carried out. Several terpenic and phenolic compounds 
were isolated, using several chromatographic techniques, namely column chromatography, 
preparative thin layer chromatography and high-performance liquid chromatography. The 
chemical structures were deduced from their physical and spectroscopic data (IR, MS, 1H and 
13C NMR and also 2D NMR – COSY, HMQC, HMBC and NOESY experiments). 
 From Euphorbia boetica Boiss. (aerial parts), several macrocyclic diterpenes, including 
one new premyrsinane-type diterpene (1), euphomyrsinane A,  and one known premyrsinane-
type diterpene, premyrsinol-3-propanoate-5-benzoate-7,13,17-triacetate (2), two new tigliane-
type diterpenes named phorboboetirane A (3) and phorboboetirane B (4), three macrocyclic 
lathyrane-type diterpenes, euphoboetirane A (5), epoxyboetirane A (6) and epoxyboetirane K 
(7), a phenolic compound, methyl gallate (8) and a cycloartane-type triterpene, 24-
methylenecycloartanol (9), were isolated. 
 
 







 Reporting to the various compounds, between family members, their chemical 
structures were very similar, differing only in unique acylation patterns. Compounds 1 and 2 
had different acylation patterns at C-3, while compounds 3 and 4 had different acylation 
patterns at C-5 and C-12. On the other hand, compounds 5, 6 and 7, not only had different 
acylation patterns at C-3 but also at C-6. Compound 5 has an exocyclic double bond at C-6/C-
17, while compounds 6 and 7 have an epoxy group at the same location. Other compounds, 
such as methyl gallate (8), which was obtained in large quantities, was methylated and, after 
reaction with hydrazine, condensed with several aromatic aldehydes affording three 
derivatives. 
From Euphorbia pubescens Vahl (aerial parts), one macrocyclic jatrophane diterpene 
polyester, euphopubescenol (10) and a diterpenic lactone, helioscopinolide A (11), were 
isolated. 
 





 As mentioned above, methyl gallate (8) was isolated in large amounts. Therefore, a 
small set of derivatives was developed through molecular derivatization, taking advantage of 
its simple structure and chemical reactivity. At first, methyl gallate was methylated, using 
dimethylsulfate, yielding methyl 3,4,5-trimethoxybenzoate (8.1), which was used in a reaction 
with hydrazine to yield the carbohydrazide, 3,4,5-trimethoxybenzohydrazide (8.2). The 
carbohydrazide was then condensed with several aromatic aldehydes, yielding three derivatives 
bearing an imine moiety (compounds 8.3-8.5).  
 
 





 Widely used in traditional medicine to treat warts, skin ulcers and tumours, Euphorbia 
species have been a source of many bioactive compounds. Among these compounds 
synthesized by Euphorbia plants, a wide variety of unique macrocyclic diterpene polyesters 
have shown promising activity when it comes to multidrug resistance reversal in cancer cells, 
according to other authors.  
This work represents a contribution, not only for the phytochemical studies of 
Euphorbia boetica and Euphorbia pubescens, but also corroborates the importance of further 
research of this genus in order to find new and effective anti-tumour lead compounds. 
The isolated compounds and those obtained by derivatization will be evaluated for their 
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